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Abstract 
 
 
Over the past few decades, Cluster Randomized Trials (CRT) have become a design of 
choice in many research areas. One of the most critical issues in planning a CRT is to ensure that 
the study design is sensitive enough to capture the intervention effect. The assessment of power 
and sample size in such studies is often faced with many challenges due to several 
methodological difficulties.  
While studies on power and sample size for cluster designs with one and two levels are 
abundant, the evaluation of required sample size for three-level designs has been generally 
overlooked. First, the nesting effect introduces more than one intracluster correlation into the 
model. Second, the variance structure of the estimated treatment difference is more complicated. 
Third, sample size results required for several levels are needed. 
In this work, we developed sample size and power formulas for the three-level data 
structures based on the generalized linear mixed model approach. We derived explicit and 
general power and sample size equations for detecting a hypothesized effect on continuous 
Gaussian outcomes and binary outcomes. To confirm the accuracy of the formulas, we 
conducted several simulation studies and compared the results. To establish a connection 
between the theoretical formulas and their applications, we developed a SAS user-interface 
macro that allowed the researchers to estimate sample size for a three-level design for different 
scenarios. These scenarios depend on which randomization level is assigned and whether or not 
there is an interaction effect. 
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Chapter I 
Introduction 
 
 
Over the last few decades, randomized controlled trials have become the design of choice 
in medical sciences and disease prevention research for the evaluation of new medical 
interventions. In such trials, an important issue in the design stage is the unit of randomization. 
This unit could be the individual patients, the physicians, a group of physicians within a practice, 
or several practices within a specific geographic area. 
In some situations, randomization at the individual level has advantages because it 
minimizes the risk of covariate imbalances. For example, different practices tend to have 
different types of patients with their own characteristics. Furthermore, trials that randomize 
individual patients can use practices as blocks to reduce the dependency of the outcomes on 
practice level discrepancies, such as the degree of adherence to a study protocol or the difference 
in clinical skills found amongst the providers. 
 In other situations, however, the interventions are randomized not to individuals but to 
intact groups or clusters, such as medical practices, worksites, families, or communities. These 
studies, referred to as Cluster Randomized Trials (CRT), are being used increasingly because of 
many reasons. First, randomizing at cluster level might be the only feasible method of 
conducting a trial in certain fields. Examples include studies where interventions are targeted at a 
whole practice (the implementation of a new Electronic Health Record system) or a whole 
community (introduction of new water and sanitation schemes). Second, randomizing by cluster 
can be used to reduce the likelihood of contamination, which is likely to happen when 
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individuals receive an intervention within the same group share information with each other. For 
example, patients in an intervention group who are being educated on colon cancer screenings 
might talk to the control-allocated patients visiting the same practice, who in turn will ask for the 
screening themselves or might respond differently on the outcome measures due to this 
influence. Third, CRT is justified when the efficacy is established at individual level, but the 
primary goal is to measure the effectiveness when an intervention is applied at the cluster level, 
or when the desire is to capture the mass effect of an intervention on a large proportion of group 
members (Murray, 1998). 
 One of the most critical issues in designing a cluster randomized experiment is to ensure 
that the study design is sensitive enough to capture the effect of the intervention. This important 
task involves making a decision about power and sample sizes. Good study design requires the 
planning of sample sizes so that the test for the intervention effect has adequate statistical power 
to detect the smallest difference that is of scientific or practical interest. Insufficient sample sizes 
can lead to inadequate sensitivity, whereas excessive sample sizes can be a waste of time and 
valuable resources. 
In the design stage of a cluster randomized study, researchers are required to answer three 
fundamental questions: (1) What are the minimum numbers of subjects in each cluster and the 
number of clusters that are required in order to attain a specified power for testing the treatment 
effect? (2) Is it better to investigate more clusters with fewer subjects in each cluster, or fewer 
clusters with more subjects in each cluster? (3) If there is a budget constraint, what is the 
optimum allocation of the sample sizes which will still allow for the desired power? To date, 
there are no definite guidelines that simultaneously answer the above questions. 
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The impact of randomization by cluster on the required sample sizes can be quite 
substantial. Campbell et al. (2004) provided a simple example to illustrate this impact. In a study 
to evaluate the effectiveness of educational training on asthma management for general 
practitioners, the intention of the design was to detect an increase in appropriate management of 
asthma patients from 40% to 60%, at a statistical power of 80% and significance level of 5%. 
From the researchers’ calculation, an individual-based sample size formula yielded a total 
sample size of 194 patients. However, when appropriate adjustment for clustering by general 
practice was taken into account, even with a small clustering effect, the true sample size 
requirement was 400. This sample size is more than twice the sample size computed under the 
assumption of no clustering effect, a significant difference that cannot be ignored. 
The assessment of power and sample size in studies involving clustering is faced with 
many challenges. First, the cluster effect must be taken into account. While standard sample size 
calculations operate under the assumption of independence between individuals, this assumption 
is violated in CRT. Second, in cluster studies, there is more than one component of variation: the 
variation among individuals within clusters, and the variation in the outcomes between clusters. 
It is essential that both sources of variation are taken into account in the design stage. Third, 
planning for a CRT involves more than just one sample size. The number of data units at each 
level required to reach a target level of statistical power must be determined. Furthermore, each 
sample size at a different level will affect the power differently. For example, in the study 
evaluating the appropriate management of asthma patients, the power of the test used to detect 
the intervention effect depends not only on the sample size of the patients within each practice, 
but also on the number of practices involved as well as the ratio of number of patients to number 
of practices.  
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Complicating matters further, the difficulty in computation of power in CRT arises from 
the complexity of the models. Much of the work on power and sample size requirements for 
cluster data is developed from the idea of multistage sampling, which creates a hierarchically 
nested structure with sample from one level nested within sample at another level. However, a 
sample taken from m clusters each of size n is not a simple random sample of mn individuals, 
and the sampling distribution of statistics on such clustered samples is not the same as that based 
on simple random samples of the same size. 
Different nesting structures can be seen in practice. One common structure is the two-
level design in which individual subjects are nested within clusters. For example, in trials where 
different interventions to improve quality of care are compared, the intervention is implemented 
at the level of healthcare professionals (e.g., clinicians, physicians, caregivers), while the effects 
are measured at the patient level. In such trials, patients are nested within healthcare 
professionals, creating the two-level nesting effects. 
During the last two decades, the design and analysis techniques for CRT with two levels 
have been fairly well-developed in the literature (Donner and Klar, 2000; Murray, 1998). In 
addition, statistical software for the two-level design is currently available; some are free to the 
public (Hedges and Hedberg, 2007; Raudenbush & Liu, 2000; Snijders and Bosker, 1993). 
However, most work on power analysis and sample size determination for CRT has only 
emphasized two-level designs, and some only handled one particular type of outcome variable. 
As a more recent development, randomized trials with three-level designs have become a 
common application in many different research areas, such as psychology, education, and 
medical sciences. Examples of three-level designs are abundant in the literature. Three of them 
will be listed here for illustration purpose. 
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In the first example, a cluster randomized controlled trial was designed to evaluate a 
school-based prevention program on tobacco and drug use. In this study, 170 schools from 9 
centers from seven countries (Austria, Belgium, Germany, Greece, Italy, Spain, Sweden) were 
randomized to one of three arms of an intervention (basic curriculum, basic with peer 
involvement, and basic with parent involvement) or to a control group. Twenty seven schools 
dropped out after the allocation to the study arm, leaving 143 schools and 345 classes actually 
included in the study. The number of schools varied between centers, as did the number of 
classes. Of 7409 eligible students, 7079 (95.7%) participated in the baseline survey. The 
evaluation is based on a comprehensive social influence approach, and was delivered during the 
school year 2004–2005 to a population of 12 to 14-year-old students attending junior high 
school. An anonymous questionnaire administered before and after the intervention was used to 
track behavioral and attitudinal changes. This cluster randomized trial assumed a three level 
structure in that students, classes, and school served as the first, second, and third level in the 
hierarchy, respectively. Randomization took place at the third level (schools) (Faggiano et al., 
2007). 
In the second example, researchers in Spain conducted a cluster randomized study to 
assess the effectiveness of a new “Experimental Program for Physical Activity Promotion” 
(PEPAF) in increasing physical activity in inactive patients. PEPAF is a program designed to 
increase physical activity in patients who did not meet the recommended aerobic physical 
activity levels. Physicians who participated in PEPAF provided patients with advice on using 
health promotion websites and health educational materials. In addition, a 15 minute consultation 
on individualized physical activity plan was offered to patients who committed to increase their 
activity level. Control group physicians delivered standard care and delayed any new systematic 
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intervention related to physical activity until the end of the study, unless the reason for 
consultation or the patients' health problems were directly related to inactivity. Recruitment 
involved inviting all 15 research groups of the Health Promotion Primary Care Research 
Network to participate, with a collaboration of at least 4 physicians per center as the requirement 
for eligibility. Seventy family physicians from 13 primary care centers belonging to 8 research 
groups agreed to participate. After signing a collaboration consent form, all 70 physicians were 
randomized to either the PEPAF or usual care (control) arm of the trial in a 1:1 ratio. Twelve 
physicians dropped out before the start of the study because of technical complaints, and 2 
physicians failed to participate. Finally, 56 physicians (29 allocated to the PEPAF arm and 27 to 
the control arm) performed the study at 13 primary care centers. Each family physician recruited 
150 patients aged 20 to 80 years, who did not meet the recommended aerobic physical activity 
level. Physicians assessed the patients' physical activity with assistance of a computerized 
algorithm. The study was managed online using Web-based software designed to help physicians 
follow the research protocol and control the recruitment process of each eligible patient. This 
study is an example of a three-level design in which patients (level one) are nested within 
physicians (level two), and physicians are nested within centers (level three). Randomization 
took place at the second level (physicians) (Grandes et al., 2009). 
In the third example, a randomized, controlled study was conducted by the Virginia 
Ambulatory Care Outcomes Research Network to compare the effect of an interactive web-based 
personalized healthcare record and the usual delivery of preventive services. Eight primary care 
practices in Northern Virginia were recruited. Practice size ranged from 2 to 35 clinicians.  Of 
the 80,000 active study site patients, 4,500 active patients were randomly selected for study 
participation.  The study sample was then randomly assigned to intervention (n=2,225) and 
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control (n=2,225) groups. Patients in the intervention group received up to three mailed requests 
from their clinician inviting them to use myPreventiveCare, a web-based personal health record 
that provides patients personalized prevention plans and individualized educational material 
about preventive services and chronic disease management. Control patients received “usual” 
preventive care and were not informed of myPreventiveCare.  Outcome measurements included 
the percentage of intervention patients who visited myPreventiveCare, percentage of patients 
who were up-to-date with indicated preventive service, and an aggregated percentage of 
preventive services that were up to date. This study can be considered an example of a three-
level design in which patients nested within physicians, and physicians nested within practices. 
Randomization took place at the first level (patients) (Krist et al., 2010). 
The three examples above show that analyses for nested cluster data do not always 
consist of two levels. It is not uncommon that a three-level design is encountered in practice. 
Hence, it is important that the three-level structure is taken into account right at the design stage 
of the experiment. 
In this work, we develop sample size formulas for the three-level data structures based on 
the generalized linear mixed model approach. We derive explicit and general power functions 
and sample size equations for detecting a hypothesized effect on continuous Gaussian outcomes 
and binary outcomes. In addition, we present a SAS macro that will allow the users to estimate 
sample size for three-level data structures in different scenarios depending on which level 
randomization is assigned and whether the interaction exists. 
We begin by providing some background and significance of this work in Chapter 2. 
Chapter 3 reviews basic statistical properties of cluster data and the general concepts behind 
power and sample size computation. Chapter 4 derives the formulas for sample size and power 
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for continuous Gaussian outcome. Chapter 5 derives the formulas for sample size and power for 
binary outcome. Chapter 6 presents a simulation study to verify the accuracy of the proposed 
formulas. Chapter 7 explains the development of a SAS macro to compute power and sample 
size, together with some practical examples to illustrate the use of the macro. Finally, Chapter 8 
includes a discussion of the current and future work. 
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Chapter 2 
Background and Significance 
 
 
Over the past three decades, the application of cluster randomized trials has led to a large 
body of methodological work and a growing literature that cuts across several areas of research. 
It has been well known that standard methods for controlled trials randomized at individual level 
cannot be applied directly to trials randomized at the cluster level. Thus, increased attention has 
been developed toward the design and analysis of CRT because of their special statistical 
characteristics.  
Despite the large amount of literature and discussions dedicated to the topic of CRT, the 
selection of proper statistical approaches to determine sample size still remains a challenge for 
researchers in multiple disciplines. The literature on sample size computation for two-level data 
can be found consistently during the last two decades, and some publications on sample size for 
three-level design also appeared recently. It is important to take a general look at the previous 
work and evaluate the impact of recent developments in this topic.  
This chapter provides a detailed review of several main issues in the development of the 
designs and analyses of CRT in general, and of the sample size estimation for multilevel data in 
particular. The chapter is structured as follows: Section 2.1 gives a general overview of the 
established literature in CRT. Section 2.2 presents issues concerning sample size determination 
and power assessment. Section 2.3 reviews statistical software that compute sample sizes in 
CRT. Finally, Section 2.4 discusses the significance and motivation behind this work. 
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2.1 Review of Statistical Issues in Cluster Randomized Trials 
Although the concept of a cluster randomized study dates decades ago when Kish (1965) 
introduced the technique of cluster-sampling design in survey sampling theory, increased interest 
in its statistical features was brought to the general research community by Cornfield (1978). In 
his work, Cornfield pointed out that two primary concerns needed to be addressed in experiments 
where groups (or clusters) of subjects are randomized. First, the variance between clusters is the 
dominant factor in the variance of cluster means. Second, there will be fewer degrees of freedom 
to estimate the between cluster variance than to estimate the within cluster variance.  
Over the years, issues involved in the design and analyses of clustered data have been 
discussed extensively by several researchers; examples include Klar and Donner (2001), Murray 
et al. (2008), and Dedrick et al. (2009). Based on the review of methodological and technical 
literature, three broad topics set the stage for discussion in the design and analysis of clustered 
data: (1) Issues in the experimental designs, (2) Issues in the selection of appropriate analytic 
models, and (3) Issues in the assessment of power and sample size determination.  
We will discuss the first two items in this section. The last item, the review on power and 
sample size estimation, will be explored separately in the next two sections because it is the 
focus of this work. 
 
2.1.1 Issues in Experimental Designs 
 A number of experimental designs have been specifically proposed for cluster 
randomized trials. The three most popular designs are matched-pair, stratified, and completely 
randomized trials. The last form of design is usually considered with no pre-stratification or 
matching on the baseline characteristics. 
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 Freedman et al. (1990) explored the gain in efficiency obtained from the matched-pair 
design by estimating the relative efficiency of an unmatched versus a pair-matched design. 
Defining the relative efficiency as 1 minus the ratio between the variance of matched design over 
the variance of unmatched design, the authors showed that the matched design can be more 
efficient compared to unmatched design when high correlation between the pairs was created 
from the effect of matching.  
 One commonly adopted matching factor is cluster size where clusters are grouped into 
categories such as small, medium, or large. As Donner and Klar (2000) suggested, this method is 
appealing because it helps to avoid the imbalance in the number of subjects per treatment group. 
In addition, the cluster size itself might associate with factors associated with other baseline 
variables, such as socioeconomic status or access to healthcare resources. 
The stratified design can be viewed as an extension of matched-pair design in which 
more than one cluster is randomly allocated within strata to each of the treatment arms. This 
design is preferred over the matched-pair design in situations when it is difficult to create close 
matches that correspond to important estimates. In addition, stratified design is more appealing 
because its allocation scheme is less rigid since it reduces many of the analytic limitations 
associated with matched-pair design ((Donner and Klar, 2000). In general, the choice between 
matching and stratification depends on the number of clusters, the accuracy of the matches, and 
the analytic plan (Murray, 1998). 
A completely randomized design with no pre-stratification or matching is perhaps the 
most commonly adopted design in practice. In any case, for all forms of designs the issue arises 
in the choice of which level randomization is executed. Zucker (1990) discussed the difference in 
the context of two-level design, in which subjects are nested within clusters. The treatments can 
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be assigned in two different ways. In the first scheme, the assignment of the treatments is done 
on the individual basis within each cluster. In the literature, this is known as subject-level 
randomization. The second option is to randomly assign the clusters to different treatment arms. 
This is known as cluster-level randomization where the subjects are nested in clusters, which in 
turn are nested in the treatment groups.  
 
2.1.2 Issues in the Selection of Appropriate Analysis Models 
To date, there is no single agree-upon method to analyze data from CRT. According to 
Murray (1998), one major source of errors in the analysis of clustered data is model mis-
specification. The selection of proper statistical approaches in clustered design is difficult 
because the usual assumptions under familiar methods are not met. Methods involving general 
linear models or generalized linear models are inappropriate for the analysis of clustered data 
because they only allow for one source of random variation, usually by ignoring the cluster 
effect, or treating the cluster as a fixed effect in the model. Zucker’s (1990) pointed out the 
pitfall in implementing such strategies by comparing what he defined as the fixed effect model 
(cluster is treated as fixed effect) and the mixed effect model (cluster is treated as random effect). 
By looking at the F-test, Zucker concluded that ignoring the cluster effect can inflate the Type I 
error and the level of inflation can be quite substantial when one mistakenly treats the clusters as 
a fixed effect. 
One strategy that has been recommended for clustered data is the use of a multilevel 
model, also known as a hierarchical linear model, or random coefficient model. This type of 
model is common in educational and social research, originally applied for longitudinal data and 
growth data. In the last decade, this technique has been used in the context of CRT because of 
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the hierarchical structure of the data. In essence, multilevel modeling provides for components of 
variance for cluster and individual slopes as well as intercepts. These models can be specified by 
using equations for each level or combining equations at each level into one. An introduction to 
multilevel modeling was written by Raudenbush (1993). The theory and implementation of 
multilevel models were discussed in depth by Hox (2002).  
The strength of the multilevel model lies on its ability to incorporate both fixed and 
random effects while allowing for unbalanced data and flexibility in handling missing data 
(Raudenbush, 1993). However, some issues still remain controversial in the application of 
multilevel models. For example, one issue involves the selection of predictors. As Dedrick et al. 
(2009) pointed out in their review, variable selection in multilevel models can be complicated 
and can easily become a source of error. Predictors can be selected for each level of the model, 
and interactions between predictors can be included at either one single level or across all levels. 
Another issue refers to the requirement of centering and the methods that accomplish this. One 
approach is to center around the grand mean of the predictor variable, another approach is to 
center around the cluster mean, or around a theoretically meaningful value. While the use of 
centering was not explicitly stated in many research studies, different methods have different 
implications for interpreting the parameter estimates (Raudenbush and Bryk, 2002).  
Another technique to analyze CRT data involves the use of permutation tests. This 
method was first discussed by Gail et al. (1996) and was reviewed by Murray (1998). In this 
approach, the distribution of all possible allocations of the clusters was examined, and the 
intervention effect for each allocation is estimated under the null hypothesis. The observed 
intervention effect is regarded as just one possible intervention effect among many, and the 
probability of getting a more extreme result is the proportion of possible intervention effects that 
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are greater than the observed effect. The benefit of a permutation test is that it does not rely on 
statistical models for its validity. In their simulation work, Gail et al. reported that permutation 
tests had satisfactory type I and type II errors. However, the disadvantage of this method arises 
when covariates were included in the model. In such situations, this technique requires as many 
assumptions as other model-based methods (Murray, 1998).  
Of all the statistical models being used to analyze cluster data, the most common one is 
the mixed model ANOVA/ANCOVA approach. This method is popular not only because of its 
computational simplicity, but also because of its ability to facilitate the estimations of models 
with fixed effects, random effects, or both. Of course, both mixed model ANOVA and 
ANCOVA are special cases of the generalized linear mixed models, which include random 
effects, random coefficients, and covariance patterns models. Murray (1998) illustrated the 
implementation of mixed model ANOVA/ANCOVA to analyze data collected from post-test 
only CRT, pre-test-post-test CRT, and CRT under both cross-sectional designs and cohort 
designs. In the cases of mixed model ANCOVA, regression adjustment for covariates was used 
to reduce bias and improve the precision. In their simulations, Murray and Wolfinger showed 
that the mixed model ANOVA/ANCOVA with one or two time intervals has a nominal type I 
error rate. They concluded that when properly executed, mixed model ANOVA/ANCOVA can 
provide a valid analysis for CRT (Murray and Wolfinger, 1994). 
One should keep it in mind that no matter what statistical model is used to analyze the 
data, designs with more than one level will call for more complex variance structures. The 
questions are how to best specify the covariance structure for the model, is there an interaction 
effect, and which level varies randomly and which level is fixed. Dedrick et al. (2009) classified 
the covariance parameters into three groups. The first group includes those that are assumed to 
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be zero and can be ignored. The second group includes those that are not zero and are supposed 
to be estimated. The third group includes those for which the researchers are unsure. When many 
in-doubt variables are omitted, researchers are faced with the risk of biased results and incorrect 
conclusions. When too many questionable variance parameters are included, the model can be 
come too complicated to estimate and estimation algorithms might not converge. 
 
2.2 Review of Issues in Sample Sizes Determination  
Although there is a large and growing literature on cluster randomized trials, the amount 
of publications on power and sample size is found to be much less than the literature that focused 
on model development and parameters interpretation. Let’s explore the reasons behind the lack 
of discussion on power and sample size assessment for cluster data. 
As Donner and Klar pointed out in their book (Donner and Klar, 2000),  one obvious 
reason that computing of sample sizes is more complicated in CRT is because the total sample 
size for each level must be determined. In a simple randomized trial, power is a monotonic 
function of the sample size when other factors are constant. This is not the case for clustered 
data. For example, in situations with a large intracluster correlation coefficient, increasing the 
number of subjects in each cluster or the total number of subjects up to a certain point may not 
have a significant impact on power. In fact, several authors have discussed methods of sample 
sizes and power optimization. In these methods, usually a range of sample sizes at each level are 
recommended along with their corresponding estimated powers (Snijders and Bocker, 1993; 
Raudenbush, 1997).  
Another reason why much less research has been devoted toward sample size 
determination is because the cluster design must be taken into account. In cluster trials, the usual 
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standard sample size assumption is violated because data on subjects within the same cluster are 
no longer independent. This level of dependency is measured and explained via the concept of 
intraclass correlation coefficients (ICC), the ratio of the between cluster variability to the total 
variability. However, computing the ICC is problematic due to the difficulty in estimating the 
variance. Estimates of ICC values are rarely available, and not all published records of the ICC 
are reliable (Hedges and Hedberg, 2007). This is understandable, however, because the 
magnitude of the ICC depends largely on the study design and outcomes, the intervention, and 
the covariate adjustment (Guittet et al., 2005). 
A third reason why there is much less discussion on sample size and power analysis is a 
misconception about the sample sizes itself, according to Donner and Klar (2000). Trials that 
enroll a large number of subjects usually give an impression of sufficient power, when in fact it 
may not be the case when the cluster effect is taken into consideration. For example, with a large 
ICC value the information drawn from any given individual in the cluster is redundant given the 
information available from other members in the same cluster. Thus, only adding more clusters 
will have an effect on power in this situation (Donner and Klar, 2000). 
Despite the difficulties in estimating statistical power and the required sample sizes in 
cluster studies, in recent years there has been considerable effort devoted to this topic. The 
resulting literature is seen in many textbooks and journals. Some main topics can be identified, 
including (1) the importance of the ICC and how to estimate its value, (2) issues involving the 
number of clusters and cluster size, and (3) analytical methods that provide formulas to compute 
the sample sizes in different situations. 
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2.2.1 The Impact of ICC on Sample Size 
It is established that the ICC has a direct relationship to the estimation of sample size and 
power analysis in a CRT. A number of authors have discussed this relationship (Hsieh, 1988; 
Murray, 1998; Donner and Klar, 2000). In a study on a complete cluster randomized design with 
normally distributed continuous outcome, Guittet et al. (2005) quantified the influence of the 
ICC on the power by examining power contour graphs under different values of the ICC. The 
authors concluded that underestimating the ICC can seriously under-power the trials. Together 
with lower number of clusters, the desired power might not be achieved. In another study, Maas 
and Hox (2005) explored the effect of the ICC on sufficient sample size and accurate estimation 
of parameters. The authors advocated that the estimated parameters and standard errors are 
biased downward when the cluster sizes are small (less than 30) and the ICC values are large 
(ranging from 0.10 to 0.30). These findings confirm the impact of ICC on sufficient sample size 
and parameters estimation, given the fact that most CRT used less than 30 clusters. 
Since knowledge of the ICC is essential for power and sample size determination in 
planning for a CRT, several researchers have attempted to address the issue of obtaining 
reasonable values for the ICC in realistic situations. One way to obtain this information is to use 
the ICC estimated by previous studies. For example, Murray et al. (2004) reported a summary of 
ICC values collected from 14 articles that provided information on the ICC for health-related 
outcomes.  In educational research, a compilation of ICC values of academic achievement and 
related covariate effects was provided by Hedges, together with an illustration of how to use 
these values to compute sample sizes under hierarchical models (Hedges and Hedberg, 2007). 
A reliable estimate of the ICC is certainly necessary to ensure robust sample size 
calculations. Several researchers dealt with the difficulty in getting accurate estimates of the 
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ICC, including methods to compute confidence intervals. One approach was presented by Feng 
and Grizzle, using the bootstrap method by simulating results from studies with the sample sizes 
that gave the observed estimates. The ICC computed from each simulation is substituted into the 
sample size formula and the distribution of powers is provided (Feng and Grizzle, 1992). In 
another paper, Turner et al., developed methods that allow for the uncertainty in previously 
obtained ICC under the use of prior distribution of the ICC in a Baysian approach. The authors 
noticed that uncertainty in the ICC will lead to some inaccuracy in the power of the study. 
However, the risk of low power is low in a design based on a large number of clusters (Turner et 
al., 2004).  
 
2.2.2 Issues Involving the Number of Clusters and Cluster Size 
In multi-level design studies, sample sizes for more than one level need to be addressed. 
As Hox discussed in his book, the maximum likelihood methods used commonly in most 
multilevel data analysis rely on an asymptotic assumption, which imply a sufficiently large 
sample size (Hox, 2002). This begs the question what is the smallest sample size that the analyst 
would be able to accept without threatening the validity of the asymptotic assumption. In most 
cases, the problem comes from determining the number of clusters. First, as several authors have 
discussed (Murray, 1998; Donner and Klar, 2000), many CRT have a small number of clusters 
due to logistic and cost issues. Adding a new cluster (clinic, school, organization) to the study is 
more expensive than adding more individuals. Second, it is often the objective of the 
investigators to evaluate the intervention at the whole cluster level, for example, interventions 
that aim to manipulate the social or physical environment (Murray, 1998).  
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With respect to the impact of sample size of each level on power, a few simulation 
studies on two-level designs have confirmed that cluster level sample size is more important than 
the total sample size. Brown and Draper (2000) and Maas and Hox (2005) explored the influence 
of sample size on power. They showed that increasing the sample size at level 2 has a stronger 
impact on power than increasing sample size at level 1, under multiple ICC values. 
As previously noted, the number of clusters available is usually limited, but how low can 
this limit go? There have been some efforts to develop a rule of thumb in estimating sample size. 
Donner and Klar (2004) suggested that once the number of subjects per cluster exceeds  
1/(value of ICC), the power will not increase significantly as the cluster size increases. Thus, 
when the ICC is about 0.05 then it is of little value to enroll more than 20 subjects per cluster. In 
terms of accuracy in standard errors of the parameter estimates, Hox (2002) reviewed a 30/30 
rule, recommending that the researchers should recruit at least 30 clusters with at least 30 
subjects per cluster in order to obtain statistical accuracy.  
In addition to the sample sizes at each level, another issue is how to determine the sample 
size in cluster data where sample sizes are planned to be unbalanced. While many papers 
described the adopting of CRT, most of them assumed the same number of subjects per each 
cluster. The difference in cluster sizes is often ignored because there are very few appropriate 
and easy-to-use sample size formulas for this situation. Donner and Klar (2000) suggested 
replacing the number of individuals in each cluster by an average number of individuals over 
all clusters 
m
m  into the sample size formula for the balanced case, or to replace m  by , the 
largest anticipated cluster size in the sample. However, the authors admitted that there are some 
limitations in this method, in that it either underestimates or overestimates the sample size. 
Along the same line, Eldridge et al. (2006) studied sample size computation for both continuous 
maxm
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and binary data for unequal cluster sizes. In their paper, they defined the relationship between the 
design effect and the coefficient of variation of cluster size, which is the ratio of standard 
deviation of cluster sizes to the mean cluster size. Written in terms of the coefficient of variation, 
the appropriate design effect does not depend on the knowledge of individual cluster size. The 
researchers also concluded that when the coefficient of variation is less than 0.23, the effect of 
adjustment for unequal cluster size is negligible (Eldridge et al., 2006). 
 
2.2.3 Existing Methods for Computing Sample Sizes 
The increasing application of cluster randomized trials goes hand in hand with an 
increasing demand for power assessment and sample size determination. Although statistical 
methods to compute power and sample size have been developed years ago, most of these 
methods focus on the computation of power in studies with simple random samples (Cohen, 
1977; Chow et al., 2008). However, there has been some literature on methods that are 
particularly pertinent to the computing of sample sizes for CRT and multilevel design studies. In 
this review, we restrict our attentions to these publications. 
Several authors presented sample size formulas for intervention studies that use cluster as 
the unit of randomization. Hsieh (1988) provided sample size formulas and power contours for 
simple cluster randomization and stratified randomization in CRT with two levels. Hayes and 
Bennet (1999) proposed sample size calculation for CRT with three types of main outcomes: 
rates per person per year, proportions, and means. Donner and Klar (2000) considered sample 
size determination for randomized trials with continuous and binary data, under matched-pair 
and stratified designs. Eldridge et al. (2006) presented a series of sample size formulas for both 
continuous and binary data for unequal cluster sizes. 
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Power formulas for longitudinal data and repeated measured data have also been 
developed. Hedeker et al. (1999) derived formulas for sample size estimation and power 
assessment for longitudinal study. They compared the treatment means of two groups in terms of 
single degree of freedom contrasts across time. Roy et al. (2007) extended these results to cluster 
studies in which subjects are repeatedly measured over time, taking attrition rates into account. 
Their main interest is to test the treatment and time interaction for continuous Gaussian 
outcomes.  
Computing sample size for cluster randomized studies with dichotomous data is another 
topic of discussion in the literature. In a pioneering paper in 1997, Shih presented a method to 
compute sample size for correlated binary data based on generalized estimating equations. 
Expanding Shih’s work, Pan (2001) derived more explicit sample size formulas, allowing for 
different structures of covariance matrix. Dang et al. (2008), on the other hand, took a different 
direction and applied the generalized linear mixed model technique to compute the sample size 
for binary cluster data. This method has an advantage over previous approaches in that it allows 
the users to incorporate both the fixed effects and the random effects into the model.  
Due to additional factors that are involved in computing sample size for cluster data, 
some researchers have developed a less direct strategy to address the power and sample size 
questions. Their general approach is to maximize power by choosing the optimal number of 
clusters and cluster size that produce a specified target standard error of a particular parameter 
estimator. This method is based on the work by Snijders and Bosker (1993). The author used 
asymptotic approximations via simulations to obtain the formulas for the covariance matrix of 
the regression estimators. These formulas are then used to derive approximately optimal sample 
sizes that produce the desired standard error. Methods to estimate the variance of the fixed 
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effects estimators were also presented by Raudenbush and Liu (2000). The key idea of this 
approach is based on an optimization process. The variance for the parameter of interest is 
estimated first, and the sample size is computed later based on the corresponding standard error. 
The variance formulas were derived via random coefficient models. 
 
2.3 Review of Statistical Software Computing Sample Size in Correlated Data 
Computer programs and software are available for calculating statistical power or sample 
size in cluster randomized trials. This section gives a brief introduction on those programs and 
software. 
Most of the work reviewed in Section 2.2.3 was based on a basic principle to compute 
sample size. The logic of this principle is to compute the sample size for a subject level 
randomized trial and then inflate this sample size by the design effect to obtain the required 
sample size for cluster data. Campbell et al. (2004) use this key idea to develop a calculator that 
computes the appropriate design effect and thus the sample size, when the goals are comparing 
the means or the proportions in CRT. The underlying formulas were based on two-level 
completely randomized design with equal randomization and equal cluster sizes. The user is 
required to specify common factors addressing a sample size problem, including (1) the 
difference to be detected, (2) the standard deviation, and (3) the desired significance and power. 
The output is a table of number of clusters required for varying values of ICC and cluster size. 
The calculator can be downloaded at http://.abdn.ac.uk/hsru/epp/samsize. 
With respect to repeated measures data, Hedeker et al. (1999) introduced a software 
application named RMASS2. This is a free web-based application, available at 
www.healthstats.org, that builds on the concept discussed in their paper (Hedeker et al., 1999). 
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The software calculates the sample size for a two-level repeated measures design. It also allows 
for attrition and a variety of variance-covariance structures for the repeated measures. To date, 
this is the only software that handles sample size determination for studies that involve both 
clustered and longitudinal data. 
Along with their paper on determining the optimal design for a two-level design trial, 
Raudenbush and Liu (2000) presented the Optimal Design software to illustrate their ideas. In 
this free software (provided by the University of Michigan), restricted maximum likelihood 
method was used to estimate the variance of the treatment contrast. This variance is a function of 
sample size and will be minimized by different constraints. The software can compute sample 
size for a two-level design with both continuous and binary outcomes. Some extension was made 
to the three-level design with continuous data and treatment randomized at level 3. The software 
can be found at http://sitemaker.umich.edu/group-based/optimal_design_software. 
Snijders and Bosker developed the PiNT (Power iN Two-level design) program which 
estimates sample size using simulations. In the related paper (Snijders and Bosker, 1993), the 
authors derived the asymptotic formulas for standard errors of the fixed effects, e.g. the treatment 
effect, in a two-level design. Since these formulas are complicated, PiNT was written to help the 
users with their calculation. As the name suggests, this software is restricted for two-level 
studies. Other assumptions include normal response model and equal cluster size. The program 
and its manual are available at http://stat.gamma.rug.nl/snijders/multilevel.htm#progPINT. 
Most recently, two software programs were made available to researchers in computing 
sample size for cluster data, both written at approximately the same time. The first is the ML-
DEs (MultiLevel Design Efficiency using simulation) program, developed by Cools et al. (2008). 
ML-DEs is a sequence of R-scripts that set up simulation studies in order to compare the 
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efficiency of multilevel designs conditioned on a budget and with different sample sizes and 
different costs of sampling units. This is a free software package with password required from 
the authors. To run the software, however, the program R and another package called MLwiN 
are required. Information about ML-DEs can be found at 
https://perswww.kuleuven.be/~u0032822/ML-DEsimulation.html. 
Around the same time ML-DEs was introduced, MLPowSim was developed in 2008 and 
published by Browne and Golalizadeh in 2009. This is a free program designed to perform 
sample size/power calculations in multilevel models via a simulation method similar to PiNT.  
However, MLPowSim is more comprehensive that PiNT since it can handle continuous, binary, 
and count data for both two and three level designs with randomization at level three. The 
program and related information can be found at http://seis.bris.ac.uk/~frwjb/esrc.html. 
 
2.4 The Significance of Sample Size Determination in Three-Level Designs 
 Despite the fast growth observed across different research areas, the evaluation of 
required sample sizes for three-level designs has been generally overlooked in the literature. 
Although some work has been devoted to this topic of interest, a review of past studies shows 
that there are at least three issues that need improvement and invite more discussion: (1) issues in 
study designs with three-level structure, (2) issues with the statistical methods, and (3) issues in 
analysis software and programs. A closer look at these gaps in the literature will explain the 
motivation behind our work. 
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2.4.1 The Gap in Study Designs with Three-Level Structure 
It can be seen from previous sections of this chapter that although methods to compute 
sample size and power in cluster randomized studies have been widely discussed in the literature, 
most publications only focused on the two-level design.  In reality, however, researchers might 
encounter situations in which the designs and data have more complicated structure.  
Examples of three level-design experiments are seen often in practice. An experiment in 
education can involve measurements of students within classrooms and classrooms within 
schools. In medical and health intervention research, evaluations might be taken from patients 
within physicians and then physicians within centers. It is not uncommon that a researcher might 
choose to ignore the cluster effect of classrooms (level 2) and treat the educational study as a 
two-level design in which students are nested within schools. Similarly, one can “combine” the 
effects of physicians and centers into one and view the medical research example as two-level 
where clusters are the center-physician pair. The important point is that the three-level structure 
is inherent in the design and embedded in the data mentioned in the above situations —
regardless of the fact that the analysts choose to take the three-level structure into consideration 
or not. 
The issue here is not whether to ignore one level of the data or to combine two levels into 
one, but rather to ensure that the studies are planned and analyzed in the most appropriate way. 
The most prudent and appropriate strategy in any statistical work is to stay faithful to the data 
structure and to entertain as much as possible all the features driven by the study design. This 
same principle remains to be true when planning for sample size and undertaking power analysis 
in three-level studies. In other words, all three levels should be considered in the design and 
planning stage for such trials. It has been well known in the literature that ignoring the cluster 
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effect of one level can lead to inaccurate power and errors in parameter estimates (Murray, 1998; 
Donner and Klar, 2000). 
Another point that lacks of discussion amongst researchers is that most sample size 
formulas seem to apply strictly to designs where randomization takes place at the highest cluster 
level. There are more choices of study designs in reality. These choices involve, for example, the 
allocation of treatments at the second or first level. Although the assignment to treatment at 
different levels has a strong impact on the sample sizes formulas, this issue in the study design is 
rarely addressed in the literature. 
 
2.4.2 The Gap in Methods Related to Computing Sample Size  
 The technical issues and appropriate statistical models to compute sample size for three-
level design studies are still in debate and need more development. Reviewing published 
literature reveals some room for further research. For example, in a thorough study, 
Konstantopoulos (2008) investigated different sample sizes for three-level randomized designs in 
three different situations when treatment assignment is given at the first, second, and third level. 
Based on mixed models ANOVA/ANCOVA, the author introduced sample size formulas for 
each different case, allowing for the use of covariates. Unfortunately, his method is restricted 
with continuous Gaussian data and has not been expanded to binary outcomes.  
Research methodologists have also attempted to derive explicit formulas for sample size 
and power assessment in three-level studies. In their paper, Heo and Leon (2008) developed 
closed form power function and formulas for sample size to detect an intervention effect for a 
three-level data. Along the same line, Teerenstra et al. (2008) presented similar formulas but 
expressed the design effects in terms of Pearson correlation. Although both of the above studies 
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provide some guidelines in the choice of number of clusters and number of subjects per cluster 
for a three-level experiment, they only consider randomization at the third level and do not 
handle studies with binary outcomes. 
Most recently, Teerenstra et al. (2010) published an interesting work in which they 
derived sample size formulas for three-level CRT using generalized estimating equations (GEE). 
Their approach is actually an extension of Shih’s (1997) and Pan’s (2001) methods, except that 
the design effect was derived in a more elegant way. The sample size formulas presented by 
Teerenstra et al.(2010) are convenient in that they can be used for both dichotomous data and 
continuous data. However, a drawback of these formulas is that they are based a population-
average approach which is not useful when the objective is to make inference about the 
participants. In addition, the authors did not consider studies in which randomization takes place 
at the second or first level. 
 
2.4.3 The Gap in Analysis Software and Programs 
 Although in some situations a simple spreadsheet program is sufficient enough to 
compute power and sample size, in many other cases the formulas presented for multilevel 
designs are fairly complicated. Few software programs specializing in sample size estimation are 
available for CRT. The problem is, as encountered in the methodology literature, most of these 
programs apply only to two-level designs. Examples include PiNT, RMASS2, and Campbell’s 
sample size calculator. 
 To date, there are only a few statistical programs that allow for computing sample size of 
three-level models. However, there remain some limitations in these programs and some areas 
leave room for expansion. For example, although Raudenbush and Liu (2000) did incorporate a 
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short section about three-level data in their optimal design software manual, the tool they 
provided can only handle continuous normally distributed data with treatment given at the third 
level. In addition, the program does not compute sample size for three-level design with binary 
data. 
The software MLPowSim presented recently by Browne and Golalizadeh (2009) seems 
to be the most comprehensive package that handles sample sizes in CRT for continuous, binary, 
and count data. However, the method relies heavily on simulations. It is complicated to use, and 
it requires several inputs from the users. Furthermore, this software does not compute sample 
size for binary data with three-level designs, and does not allow for randomization at different 
levels. 
 
2.4.4 Goals and Motivation 
The discussion above emphasizes the importance of sample size determination in three-
level designs. Given the increasing use and the complexity of the three-level models, there is a 
need to extend the methodological issues considered and the type of applications examined. 
Although in principle, the extension from the two-level to three-level designs seems to be 
straightforward, the task is not simple and trivial. Adding another level means adding more 
complexity to the design and another sample size to determine. Not only the resulting models 
will be difficult to follow from a conceptual point of view, but the sample size formulas might be 
difficult or even impossible to derive. Given the importance of the topic, it is worthwhile to 
explore different strategies and different applications to address the issue of computing sample 
size in three-level cluster data.  
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In the work reported here, we propose a method to derive sample size formulas using 
generalized linear mixed models specifically for three-level designs. We will consider situations 
in which the treatment is randomized at the first, second, and third levels for both continuous 
normally distributed outcome and binary outcome. We will calculate power and sample size for a 
two-group (treatment and control) comparison. These methods will be implemented in a series of 
menu-driven SAS macros. The intent is not to present a method that is superior to current 
research studies, but rather to present a more comprehensive approach to address the same 
research problem. Our primary goals are to (1) gain more understanding on the theory behind 
statistical power and sample size in CRT with three level designs, (2) develop an alternative form 
of the sample size formula using available information obtained from the researchers, and (3) 
provide a user-friendly program to compute sample size for cluster randomization with three 
levels. 
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Chapter 3 
Relevant Statistical Concepts 
 
 
 Although it is clear that the assessment of sample size and power is study-specific, some 
basic requirements need to be established in order to answer most sample size problems. The 
computation of sample size depends on several factors, including the expectation of the 
researchers, the selection of the study design, the characteristics of the data, and the statistical 
methods chosen by the analyst. Without sound understanding of these factors, the estimation of 
sample size would be reduced to merely a guessing game.  
 Murray (1998) discussed specific requirements for sample size estimation, such as the 
form and magnitude of the intervention effect, the test statistic and its distribution under the null 
hypothesis, and the variance of the estimated intervention effect. Although these concepts 
generally apply to any sample size problem, sample size consideration in multi-level designs is 
further complicated by numerous factors, including the number of units for each level, the 
magnitude of the intraclass correlations (ICC), the presence or absence of the random effects, 
and the correlation structures specified in each model. 
This chapter provides a brief review of some relevant statistical concepts that are 
essential to the estimation of sample size and power analysis in cluster studies. We begin with a 
refresher on the concept of statistical power and sample size assessment in Section 3.1, followed 
by some basic characteristics of the ICC in Section 3.2. Section 3.3 revisits the discussion in the 
literature on power and sample size in the simplest case of multilevel data, the two-level design. 
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Finally, Section 3.4 offers a review of generalized linear models and generalized mixed models, 
the statistical methods that we utilize in this work. 
 
3.1 Statistical Power and Sample Size Assessment  
The concept of statistical power and sample size determination has been studied 
extensively in the literature. Excellent discussions of this topic can be found in basic statistical 
works such as Cohen (1988), Murphy and Myos (2004), Chow et al. (2008). In his book, Cohen 
(1988) presented a detailed treatment on power analysis and the corresponding formulas to 
compute power, together with numerous tables of sample sizes for different situations. Murphy 
and Myors (2004) provided an overview and introduced a set of procedures for power analysis 
under the context of general linear model. Chow et al. (2008) discussed sample size calculations 
for various study designs in clinical research. Power and sample size considerations are also 
covered in textbooks written specifically for cluster randomized trials, such as Murray (1998) 
and Donner and Klar (2000). The discussion in this section relies heavily on these 
aforementioned publications. 
 
3.1.1 Hypothesis Testing 
One of the most important objectives of statistics is to make inferences about unknown 
population parameters based on information drawn from sampled data. Methods for drawing 
inferences about parameters can be classified into two types: (1) to estimate the values of the 
parameters and (2) to establish decision rules about parameter values and apply these decision 
rules based on the data. The later method is referred to as hypothesis testing, a topic that we will 
elaborate in this section.  
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A hypothesis is an assertion or conjecture concerning one or more populations of interest. 
In other words, it is a statement about population parameters (Casella and Berger, 2005). In 
hypothesis testing, research hypotheses are constructed first, leading next to the statistical 
hypotheses. A research hypothesis is a speculation or supposition created by the researchers 
based upon past observations or previous experimental outcomes. A statistical hypothesis is a 
statement that can be evaluated by appropriate statistical methods and techniques (Daniel, 2009). 
Hypothesis tests are common in many situations in which a theory or a speculation is to 
be tested against observation. For example, a medical researcher might hypothesize that a new 
drug is more effective than a traditional drug in treating a certain disease, or an educator might 
claim that two methods of teaching are equally effective. The role of statistics in hypothesis 
testing is to make decisions when comparing the observed sample with the theory: does the 
sample agree with the researcher’s hypothesis? Should we support the hypothesis? What is the 
probability that we will make a wrong decision? And particularly, how large is the sample size 
required to reduce the chance of error and to reach the decision correctly? (Cohen, 1988) 
The structure of hypothesis testing is formulated with two statistical hypotheses: the null 
hypothesis and the alternative hypothesis. The null hypothesis is usually denoted by the symbol 
H0. Often, the value chosen in the null hypothesis is a historical value or a claim. For example, 
suppose that on average a traditional drug cures 50% patients from a certain disease, then we 
might use a null hypothesis H0 : p=0.5 for a study comparing the effect of a new drug to a 
traditional drug.  In general, the null hypothesis is set up for the purpose of being disproved. 
Thus, the complement of the conclusion that the researchers seek to prove is the null hypothesis. 
Any hypothesis that is opposite to the null hypothesis is called an alternative hypothesis, denoted 
by the symbol HA. The alternative hypothesis is a statement of what the researchers believe to be 
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true if the sample data calls for a rejection of the null hypothesis (Daniel, 2009). For instant, in 
the new drug experiment if we believe that the new drug is more effective than the traditional 
one, the alternative hypothesis can be stated as HA: p>0.5.  
 
3.1.2 Statistical Power 
The purpose of any statistical test is to reach a conclusion. One could either reject or not 
reject the null hypothesis, but hypothesis testing does not lead to a proof of a hypothesis in 
general. It merely implies whether the alternative hypothesis is supported or not supported by the 
given data. If the null hypothesis is not rejected, it means that the data do not provide enough 
evidence to refute it. On the other hand, rejection of the null hypothesis simply indicates that the 
sample evidence is sufficient enough to support the alternative hypothesis.  
What if we make a wrong decision? The states of nature can be partitioned into two 
options, either H0 is true or H0 is not true. Similarly, the decisions lie between the choices of 
whether to reject or not to reject H0. Suppose the researcher rejects the null hypothesis when it is 
in fact true, then a type I error has been committed. On the other hand, if the researcher 
mistakenly retains the null hypothesis when it is indeed false, then a type II error arises. The two 
types of errors are illustrated in Table 3.1. 
 
Table 3.1: Probabilities Associated with a Statistical Test 
                                     Our Decision 
Truth of H0 Do not reject H0 Reject H0 
H0 is true Correct decision (1 ) Type I error ( ) 
H0 is false Type II error ( ) Correct decision (1 =Power) 
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The maximum type I error probability which a researcher is willing to risk is called the 
level of significance of a test, denoted by . Usually   is specified in advance before the sample 
is drawn so that the results will not influence the level of significance of the test. The probability 
of making a type II error is denoted by . In hypothesis testing, it is desirable to choose   and 
  as small as is practical. 
Power is the probability of rejecting the null hypothesis when it is in fact false. To phrase 
differently, power is the probability that the test will be able to detect that the alternative 
hypothesis holds when that is the true hypothesis. It should be noted that both power and type I 
error probability are functions of the interested parameters. In Table 3.1, power is represented by 
the quantity 1  , or one minus type II error probability. 
One common question is how much power we can expect to achieve given a level of 
significance. A decision not to reject H0 (first column) means the researchers either made a 
correct decision or committed a type II error. By the same token, a choice of rejecting H0 
(column 2) means the researchers either made a correct decision or to committed a type I error. 
Thus, it is incorrect to criticize a researcher who rejected H0 to have committed a type II error. In 
contrast, a researcher who did not reject the null hypothesis is exposed to type II error and his 
study might be vulnerable to the lack of power. One cannot conclude a new drug is ineffective in 
a study with low power because such study would have little chance of detecting a statistical 
difference between the two drug treatments. (Donner and Klar, 2000). 
 
3.1.3 Sample Size Calculation in General 
Sample size calculation is a process of computation that yields the size of the sample 
required to test a specific statistical hypothesis stated by the researchers. In general, to determine 
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a sample size, researchers are required to specify four pieces of information (1) the significance 
level, (2) the desired power, (3) the effect size, and (4) the standard error of the effect size. We 
will discuss these concepts in the context of a clinical trial testing the effectiveness of a treatment 
between intervention and control groups. 
As defined previously, the significance level represents the probability of mistakenly 
rejecting the null hypothesis, and the power reflects the probability of correctly rejecting the null 
hypothesis. In a typical experiment, a significance level of 5% is chosen. In the literature, a 
conventional desired power is often set at 80% or 90%. 
The effect size is a measure of the difference between the two groups that is judged to be 
clinically important. In general, if the researchers are settled for a large effective size, a smaller 
sample size is needed. However, if the effective size is relatively small, a larger number of 
subjects will be required. Researchers should keep the structure of the effect size as simple as 
possible. For example, if several differences amongst the means are of interested, only one 
should be chosen as the primary outcome. Similarly, if there are different treatment groups, only 
two that relate to the contrast of primary interest should be considered (Murray, 1998). 
Finally, knowledge of the standard deviation of the main outcomes is important for 
sample size estimation. As a general rule, a very precise method of measurement will detect any 
given difference with a much smaller sample size compared to the sample size required with a 
less precise method of measurement. In cluster randomized trials, the knowledge of standard 
deviation is usually connected to the expression of the variance of the estimate of the 
intervention effect, which we will discuss later. 
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Snijders and Bosker (1993) proposed the following formula to link the four quantities 
required in a sample size calculation together, under the normal distribution assumption for the 
variable associated with the effect size: 
    11 /2Z ZSE 

    
In this formula,  is the significance level of the test, 1   is the power of the test,  is 
the effect size,  SE  is the standard error of the estimated effect size, and 1 ( 2)Z   and 1Z  are 
the quantiles of the standard normal distribution associated with the values of 1 2  and 1  .  
It can be seen from the above formula that given three out of four factors, the fourth 
factor can be computed. In many types of designs in practice, this formula is a valid 
approximation that can be used to compute the sample size required for a certain level of power. 
In multilevel designs, however, more than one level of sample sizes is needed. Difficulty also 
arises in determining the standard error of the estimated treatment effect in cluster randomized 
trials. We will turn to the details of this discussion later in Section 3.3. 
 
3.2 Intraclass Correlation 
The sampling of subjects into experiments via clusters introduces special considerations 
that need to be addressed in sample size determination and power analysis. Outcomes measured 
from subjects within the same clusters tend to be similar and are not independent. In the 
literature, this level of dependency—the effect of clustering—is estimated by the measurement 
of the intraclass correlation. In this section, we will discuss the effect of clustering in two-level 
designs and then expand the idea to three-level designs. 
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3.2.1 The Effect of Clustering in Two-Level Designs 
 Consider an experiment in which sample of clusters of individuals are randomly assigned 
to two experimental groups: treatment and control. Let represent an observation from the iijkY
th 
subject within the jth cluster within the kth treatment, and let the variable have a common total 
variance of 
ijkY
2 . Let all clusters have the same n number of subjects, and each of the two 
treatment arms have the same number of m clusters. The variance of a cluster mean is  
  2CVar Y n  
where 2 is the within cluster variance. 
 Furthermore, assuming constant variance across the clusters, the variance of the treatment 
mean can be written as: 
    2TVar Y mn  
 Since the units of randomization are clusters, the dependency between individuals within 
the same cluster exists. In such situation, the total variance can be decomposed into two 
components, a between cluster variance 2B  and a within cluster variance 2W , so that 
2 2
B W
2    . 
 To take into account the effect of this dependency, we introduce the quantity intraclass 
correlation, denote by  , into the variance formula. Here, the parameter  can be viewed as the 
pair-wise correlation coefficient between any two measurements in the same cluster, meaning 
. With the assumption that  ',ijk i jkCorr Y Y     is positive, we can also interpret   as the 
fraction of the total variation in the data that is attributed to the unit of assignment. In other 
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words,  is the proportion of the total variance that is accounted for by the between cluster 
variation: 
2
2 2
B
W B
     
Methods to estimate the ICC were reviewed in Chapter 2. A classical approach is to apply 
the analysis of variance among and within cluster. In this method, the ICC is obtained by the 
following equation: 
  
2
2 21
B
B W
SMSC MSW
MSC n MSW S S
      
Where:  
 MSC and MSW are the mean square error between and within cluster respectively.  
  MSC
n
 MSW  and are the estimates of 2B2B 2WS MSW  and 2W respectively. S
 
With clusters serving as the units of randomization, the variance of cluster mean now takes a 
different form that reflects the variation between groups and within members: 
  2 2WC BVar Y n    
And the variance of treatment mean is: 
  2 2W BTVar Y mn m    
Written in terms of the total variance and  , the final formula yields: 
      2 1 1TVar Y nmn       
A few implications can be drawn from the above equation: 
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 When the estimated value of   is zero, the formula for the variance of treatment mean is 
reduced to the usual form of the variance of treatment mean under the assumption of 
independence amongst cluster members. On the other hand, when  =1, we have the total 
dependence situation. In this case, all measurements in a cluster are identical and the total 
information gained from a cluster is no more than information gained from a single 
member (Donner and Klar, 2000). 
 The variance of the treatment mean in cluster randomized trials equals the variance of 
treatment mean under the assumption of independent errors multiplied by a quantity of 
 1 1n    in two level-designs. This quantity is called the variance inflation factor, or 
the design effect. As we will see later, the design effect plays an important role in the 
estimation of sample size (Murray, 1998). 
 Since the value of   is always positive, the design effect increases when   increases 
and when the cluster size n increases. When n is large the design effect can be large even 
with a small ICC. Thus, the variance of treatment mean is always larger in cluster designs 
than in studies without cluster effect and with equal total number of subjects (Donner and 
Klar, 2000). 
 Analytical methods that treat clusters as the unit of analysis and take proper consideration 
of the cluster effect can provide the tests for the treatment effect. However, given all 
other factors constant, the tests might have lower power than would be obtained in 
independent cases (Hedges and Hedberg, 2007). 
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3.2.2 The Effect of Clustering in Three-Level Designs 
The concept of the intraclass correlation as a measure of proportional variation can be 
extended to designs with more than two levels, the only difference is that we now have more 
variance components involved and there are different ways to define and interpret the intraclass 
correlations. 
Consider an experiment involving a three level design in which patients are nested within 
physicians, and physicians are in turn nested within centers. The total variance in the outcome 
can be decomposed into three components: The between patients nested in physicians (level 1) 
variance 2e , the between physicians nested in centers (level 2) variance 2p , and the between 
centers (level 3) variance 2c . Thus, the total variance is 2 2 2T c p 2e      . In the context of a 
three-level design, two definitions of the intraclass correlations are being circulated in the 
literature.  
The first method specifies the intraclass correlation at the physician level as 
2
2
p
T
r

  
and at the center level as 
2
2
c
T
   
  
The second method defines the intraclass correlation at the physician level as 
  
2 2
2
p c
T
r
 

  
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and at the center level as 
2
2
c
T
   
The choice of which method to apply depends on the goal of the analysts. The first 
method should be used when our focus is on decomposing the variance components across all 
levels, or on estimating how much variation is explained by each level (Hox, 2002). On the other 
hand, the second method allows for an estimation of the correlation between two randomly 
chosen subjects in the same group. For example, in the second method  represents the 
correlation between two patients related to the same physician, and  also takes into account that 
two patients seeing the same physician are visiting in the same center. In the same context, 
r
r
  
represents the correlation between two patients in different centers (and thus different 
physicians). Some authors view the intraclass correlation under the second method as an analogy 
to the Pearson correlation (Teerenstra et al., 2008). 
Similar to what we have seen in the two-level designs, the variance of the treatment 
means in three-level situations can be written as a product of the variance that would be obtained 
if all outcomes are independent and a variance inflation factor. This statement will be discussed 
with further details in Chapter 4 and Chapter 5. 
 
3.3 Computing Sample Size in Two-Level Cluster Designs 
 Before proposing the methods to compute sample size for three-level cluster randomized 
studies, a refresher on how the sample size formulas for two-level designs were derived would be 
helpful. First, we will review how sample sizes are computed in an individual randomized 
clinical trial. Next, we will discuss how the same formula is extended to a two-level cluster 
design. 
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3.3.1 Power in a Simple Clinical Trial 
Consider a simple clinical trial in which 2N subjects are equally randomized into two treatment 
groups. Let  be the observation of the iijY
th subject in the jth treatment. The model can be written: 
ij i ijY     
where  j=1,2 and i=1,..,N and 2~ (0, )ij N  . 
Suppose our hypothesis is to test the difference between the treatment effects: 
0 1:H 2       versus       1 1:H 2   
Denote the estimates of the difference in the two treatment means as 
  
1 2Y Y    
Let  2   be the estimated variance of that difference under the null hypothesis. 
Assuming equal variances in the two groups, then: 
 
2
2 2
N
     
A Z-statistic can be used to test the treatment mean difference. 

 2
z
 
  
Under the null hypothesis of no treatment effect, .We reject the null hypothesis when ~ (0,1)Z N
/2| |Z Z  
Under the alternative hypothesis that 1 2    , then , where *~ ( ,1)Z N 

*
2

 
                       
The corresponding power is given by 
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   
 
/2 /2
*
/2
| |
1
1
P Z Z P Z Z
Z
 
 

  
  
 
 
In order to achieve the power of (1 )100% , we need 
*
/2Z Z        or    * /2Z Z     
Substitute this into the equation for * above, we get 
 /22
Z Z 

 
   
 /222
Z Z
N
 


   
From here, we obtain the usual sample size formula testing the difference between the two means 
  2 2/2
2
2 Z Z
N  


  
 
3.3.2 Power in a Two-Level Cluster Randomized Trial 
Now assume that a number of m clusters, rather than individuals, are randomized to each 
treatment group. Furthermore, assuming each cluster has n subjects and the clusters were chosen 
randomly from a larger population. Thus, the total sample size is N=mn. The model becomes: 
ijk i j ijkY C T      
 where i=1,…,m, j=1,2, and k=1,…,n 
 Ci represents the cluster effect   
 Tj represents the treatment effect 
 2 )~ (0,ijk eN  and 2 )~ (0,i cC Normal   
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The intraclass correlation is defined as 
2
2 2
c
c e
     
Where 2c  is the between cluster variance and 2e  is the within cluster variance.  
The total variance of is ijkY
2 2
e c
2     
As derived in Section 3.2.1, the variance of the difference in estimate treatment means is 
   
2
2 2 1 1n
mn
        
Substitute this into the sample size equation  
 /22
Z Z 

 
   
The total sample size is now 
    2 2/2
2
2 1 (Z Z n
N  
1) 

    
Compared to the simple randomized clinical trial, the sample size in two-level cluster 
randomized trial is “inflated” by the variance inflation factor of  1 ( 1)n   . Since this variance 
inflation factor depends on the variance of the treatment means, the problem of computing 
sample size in cluster data really boils down to the problem of deriving the variance of treatment 
effect. 
 
3.3.3 Power and the Effect of Randomization 
Randomization, an important component of experimental research, can be accomplished 
through two major types of design (1) a subject-randomized design and (2) a cluster-randomized 
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design. In Section 3.3.2, we discussed the derivation of sample size formula in two-level designs 
in which group of subjects (clusters) was assigned to different treatments. However, there are 
many situations in which for a given effect size, the randomizations can occur at different levels.  
Unit of randomization plays an important role in computing sample size and power 
analysis. For example, the model presented in Section 3.3.2 is no longer true if the individuals, 
instead of clusters, are randomized. Raudenbush and Liu (2000) discussed this issue in a two-
level design applied for multisite experiment, where persons within a site are randomly assigned 
to one or two more treatments. The sample size formula in this case is more complicated, since it 
takes into account the possibility that treatment effects can vary across different sites. 
The situation is more complicated in three-level designs, when randomization could 
happen at any of the three levels. For instant, in the example discussed in Section 3.2.2, 
treatment assignment could be done at the level of patient, or provider, or practice. We will see 
in later chapters how the level chosen for random assignment will affect the variance-covariance 
structure of the statistic model and the corresponding sample size formulas. 
 
3.4 Generalized Linear Mixed Models 
 In the course of this work, we will present methods to compute sample size and power for 
three-level cluster designs based on generalized linear models (GLM) and generalized linear 
mixed model (GLMM) approaches. To stimulate further interest, this section pulls together some 
basic concepts of the GLM and GLMM. The concepts introduced here will recur frequently in 
subsequent chapters. Understanding the definitions and their relevance is important, especially 
for looking at their applications in the context of three-level design. The discussions in this 
section are drawn mainly from Brown and Prescott (2006) and Littell et al. (2007). 
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3.4.1 Linear Mixed Models 
Consider a normal linear model  
1 1 2 2 ...i i i p ipy x x x i                   
 2~ 0,i N   
In this model, the regression coefficients betas represent the fixed effects and the error term is 
the only random effect. In matrix notation, it can be written as 
   Y =     Xβ + ε
      2~ ,n nN ε 0 I
Where  is the vector of the observed values  1 2, ,..., 'ny y yY 
  1 2, ,..., 'p  β  is the vector of the fixed effects 
  1 2, ,..., 'n   ε    is the vector of the residuals 
The normal mixed model extends the above fixed effect model by including additional 
random-effect, random coefficients, or covariance terms in the residual variance matrix. Normal 
mixed effects are often appropriate for representing clustered and dependent data. In normal 
mixed models, the random effects are assumed to follow a distribution and the fixed effects are 
considered constant. In matrix notation, a typical normal mixed model takes the form 
  Y Xβ Zγ ε       
where   
Y is an n x 1 vector of observed values 
X is an n x (p +1) design matrix (of column rank p) 
β is a (p + 1) x 1 vector of fixed effects (including the overall mean ) 
Z is an n x q second design matrix for the random effects γ  
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γ  is a q x 1 vector of random effects, where  ~ ,qNγ 0 G and  2 2 2, ,...,c c c  G   
ε  is an n x1 error vector where  ~ ,nNε 0 R and 2R I  
Under the above assumptions, the variance of the observation vector can be written as 
( ) ( ) ( )V V V     y V Zγ e ZGZ R  
To give a general idea on the structure of V , consider a simple example with a study of two 
centers, each with two patients, one in each treatment. Here we have p=2 and q=2 (thus the total 
sample size is 4).  
111
221
312
422
y
y
y
y
     
y  ,     
111
221
312
422




       
ε
 
1 1 0
1 0 1
1 1 0
1 0 1
       
X , 1
2



       
β , , 
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1 0
0 1
0 1
       
Z 1
2


    
γ   
 
 
Then the variance covariance matrix V in this case is  
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                 
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 

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Note that specifying the random effects is a convenient way to form the structure of the 
variance-covariance matrix. The above model is equivalent to a fixed effects model with the 
normally distributed residuals that share the same variance-covariance matrix as specified. In 
other words, we can write   Y = Xβ + ε
With the same and Y β  and where is defined as above. ~ 0,Nε V

V
 
3.4.2 Generalized Linear Models (GLM) 
 Normal linear mixed models work under two distinct assumptions: the errors and random 
effects are normally distributed, and the response variable is modeled directly as a linear 
combination of the fixed and random effects. These assumptions are not met in many practical 
situations where data are non-normal, such as studies with binary or count outcomes. In these 
situations, Generalized Linear Models are available for fitting non-normal fixed effect models 
with three basic components. 
The first component is called the random component, referring to the response variable 
.  belongs to the exponential family with a probability density function with 
the following general form: 
 1 2, ,..., ny y yY Y
        ; exp / ,i i i i i if y y b a c y          
where  is a location parameter and  is a dispersion parameter that only appears in distribution 
with two parameters (such as normal distribution). The forms of the function a, b, and c are 
different in different distributions.  
 For one-parameter distributions, the general form can be simplified to: 
      ; exp /i i i i i if y y b a c       y  
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It can be shown that the mean and variance of the random component can be written in 
terms of a and b as follows 
      'E y b    
      ''Var y b   
Hence, we can find   by  1'b  . 
 The second component relates a vector  1 2, ,..., n  η to the model fixed effects β  and 
the predictors by a linear combinationX η Xβ . This linear combination of the fixed effects is 
called the linear predictor. 
The third component is a link function that links the linear model to the mean of Y 
through the formula 
 g  μ η Xβ   where g(.) is monotonic and differentiable 
 Eμ Y  
Note that the normal linear model is a special case of GLM in which the link function is the 
identity link  g   . 
 In general, the GLM can be defined using the matrix notation similar to normal models as 
follows 
 y μ ε  
 g μ Xβ  
Thus, the variance-covariance matrix of this model is 
     Var Var y ε V
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For a sample of n observations, the variance takes the form  V AB ,where  idiag a   A   
and  ''idiag b  B  , both are n x n matrices. For example, in the binomial distribution with 
n=4, we would have 
1
2
3
4
1/ 0 0 0
0 1/ 0 0
0 0 1/ 0
0 0 0 1/
n
n
n
n
       
A  and 
 
 
 
 
1 1
2 2
3 3
4 4
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
 
 
 
 
        
B  
 
3.4.3 Generalized Linear Mixed Models (GLMM) 
 The Generalized Linear Mixed Models are the extended version of Generalize Linear 
Models to accommodate models with random effects. The extension is carried out through the 
link function. Here, the general model takes the same form of 
 y μ ε  
However, the random effects are now added to the link function 
( )g  μ Xβ Zγ      
where  
 Y is an n x 1 vector of observed values 
 X is an n x (p +1) design matrix (of column rank p) 
 β is a (p + 1) x 1 vector of fixed effects (including the overall mean ) 
 Z is an n x q second design matrix for the random effects γ  
 γ  is a q x 1 vector of random effects independent of ε , and  ~ qNγ 0,G  
 ε is the vector of errors and E(ε )=0 and Var(ε )= AB where A and B were defined 
previously. 
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The key difference between the normal mixed model and GLMM is that ε  is not 
necessarily assumed to be normal.  
The variance of y is 
( ) ( ) ( ) ( )V V V V    y V μ ε μ AB . 
To illustrate the structure of A and B, consider a simple data set with 6  Bernoulli   
observations, we then have: 
  
 
 
 
 
 
 
1 0 0 0 0 0
0 1 0 0 0 0
0 0 1 0 0 0
0 0 0 1 0 0
0 0 0 0 1 0
0 0 0 0 0 1
t t
t t
t t
c c
c c
c c
 
 
 
 
 
 
           
B
1 0 0 0 0 0
0 1 0 0 0 0
0 0 1 0 0 0
0 0 0 1 0 0
0 0 0 0 1 0
0 0 0 0 0 1
          
A  
Discussion on how GLMM is applied in computing sample size for binary data will be 
presented with more details in Chapter 5. 
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Chapter 4 
Power and Sample Size for Continuous Outcome 
 
 
In Chapter 1, we introduced a few examples with three-level cluster design studies and 
different possible outcomes. In the simplest situation, these outcomes are continuous and 
normally distributed. In this chapter we present methods to compute power and sample size 
assuming a linear mixed model. We will derive the power formulas and the general forms of the 
variance structures for six different situations: (1) randomize at level three, (2) randomize at 
level two without interaction, (3) randomize at level two with interaction, (4) randomize at level 
one without interaction, (5) randomize at the level one with interaction between treatment and 
level three and (6) randomize at the level one with interaction between treatment and level two. 
 
4.1 Linear Mixed Model Approach 
Consider a three-level study design in which patients are nested within physicians, and 
physicians are in turn nested within centers. Let ijky be the response observed at k
th patient, jth 
physician, and ith center. Furthermore, let N be the total number of centers, p be the number of 
physicians in each center, and n be the number of patients visiting each physician (balanced 
design). The total sample size is T=Npn. 
Assuming both level two (physician) and level three (center) are random effects and no 
covariates are included, the total variance in the outcome can be decomposed into three 
components: the within physicians and between patients (level 1) variance 2e , the between 
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physicians (level 2) and within centers (level 3) variance 2p , and the between centers (level 3) 
variance 2c .  
The intraclass correlation between patients nested within the same physician and the 
same center can be specified by: 
  ' 2 22, p cijk ijk
T
corr y y r
 

   
The intraclass correlation between patients within the same center but under different physicians 
can be specified by: 
 ' ' 22, cijk ij k
T
corr y y    . 
Under mixed models notation, we can write 
Y = Xβ + Zγ + ε  
where 
 Y is the (T  × 1) vector of the observed outcome data 
 X is a (T  × m) fixed effects design matrix 
 β is a (m × 1) vector of regression fixed effects coefficients  
 Z is a (T × q) random effects design matrix.     
 γ is the (q × 1) vector of random effects,  Nγ ~ 0,G  
 ε  is the error vector,    2~ , eN ε 0 I
Follow the properties of Multivariate Normal distribution, we have where ~ NY Xβ, W
   2T e W ZGZ I       
 54
 
For any type of mixed model, the sample size and power estimates depend on the variances of 
the fixed effects, which can be found by 
  11
1
N
i
Var



   Ti iβ X V X


      (4.1) 
where  is the corresponding design matrix to center iiX
th and β  is the vector of regression 
coefficients for the fixed effects. 
Assuming the treatment effects are fixed and the model has no other covariates (m=2), 
then  0 , T β  where 0 is the expected measurement for a patient in the control group and 
0   is the expected measurement for patients in the intervention group. The hypothesis of 
interest can be written as 
: 0
: 0d



 
0
A
H
H
 
To test this hypothesis, a Wald-type test based on asymptotically normal distributions can 
be used. The asymptotic variance of  N    is determined by the right lower corner 
element of the estimated variance-covariance matrix   Var N    β β .  
The power to detect a difference of size  with a two-sided type I error rate of d   is: 
   , / 2, , / 2,1 t tN Npower t d t dVar Var      
               
 

   
where ,tT   is the cumulative distribution function of the t-distribution with   degrees of freedom 
and / 2,t   is the 100 % percentile from the t-distribution with   degrees of freedom. The value 
of  depends on the analysis method and the level where randomization takes place. 
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In many sample size problems, computing the variance estimator  Var  is the main 
task. Once  Var  is obtained, we can easily plug its value into the above formula to estimate 
power or sample size. In three-level design, power depends on the sample size of all three levels, 
i.e. the values of N, p, and n. Although in the above formula n and p do not appear explicitly, 
their roles are embedded in the computation of  Var  . The following sections derive the 
formulas for Var   for different levels of randomization. 
 
4.2 Randomize at Third Level  
4.2.1 Estimate  Var β  
Assume that the centers are randomized such that  N centers are in the treatment arm 
and (1 )N centers are in the control arm. The number of patients allocated to the treatment arm 
is  T1= Npn, and the number of patients allocated to the control arm is T2=(1 )Npn. The 
design matrix is  if the ii treat pn pn X X 1 ,1
 0pn pn1 ,

pn
th center is randomized into the treatment group, 
and if the ii control X X th center is randomized into the control group.  
When randomization occurs at level three, the matrix can be written as: V
 2 2 2p e n p n c     V I I J J  
For example, consider the ith center with two physicians and each physician has two patients. 
Then               
2 2 2 2 2
2 2 2 2 2
2 2 2 2
2 2 2 2 2
T c p c c
c p T c c
c c T c
c c c p T
    
    
2
p   
    
        
V   
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Factor out the total variance 2T , we obtain , where 2TV R
pn   1p n nr r         R I I J J    
For the example above,  
1
1
1
1
r
r
r
r
 
 
 
 
       
R  
The robust variance estimator of  N β β  is 

1
1
1
lim
N
N i
N


 
      Ti iX V X  
        12 lim 1T treat treat control controlN N N N         T -1 T -1X R X X R X  
      12 1T treat treat control control        T -1 T -1X R X X R X     
Following the derivation procedure presented by Shin (1997),  can be rewritten as 
   12 1T   
        
T -11 R 1  
  
2 1
11
T  
 
            T -11 R 1
 
 Var   is the right lower corner element of the above variance-covariance matrix , which is 
      
2
1
TVar     T -11 R 1  
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The quantity   is proportional to the design effect (variance inflation factor). This is a 
scalar with the value equal to the sum of all elements in the matrix .The exact expression of 
will be derived next.  


1T -11 R 1
-1R
 1T -11 R 1
 
4.2.2 Derivation of  T -11 R 1
This derivation is based on the work from Teerenstra (2010). The two following results 
from Henderson and Searle (1981) will be used recurrently in this section: 
Result 1: 
If  and A B  are arbitrary nonsingular square matrices of same dimension, then 
     1 11 1 1 1 1 1 1A B A A B I A B A I A B I A B A            - -+ + 1  
Result 2: 
  1 1q q q qbaI bJ I Ja a bq        
Recall that correlation matrix for a given center iR th takes the form A B R , where 
        and     1p nA I r I r J      n pnB J  
Apply result 2 , we obtain 
  1
1
1 1 1p n n
rA I I
r n r


                   
J
n
 
Let  1 1n r n     , then  
1 1
1 p n n
rA I I
r


              
J  
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   
1 1
1
1
p n n pn
pn
pn
rA B I I J J
r
nr n J
r
J
 
  


                       
  

 
Again, apply result 2 we get 
   11 pn pnI A B I Jpn      
Denote    1 1 1pn n r n p          , then 
  11 pn pnI A B I J    
Substitute the , , and 1A 1A B   11I A B  in  11 R A B    using result 1 we have 
1 1
1 pn pn p n n
rI J I I J
r
 
 
               
R   
Thus, 
1 1
1
T T
pn pn p n n
rI J I I J
r
 
 
                 
1 R 1 1 1  
 1 1 1 1
1
T T
pn
n rpn J
r

 
           
1 R 1 1 1  
  1 1 1 1
1
T n rpn ppn
r
 n
  
            
1 R 1  
Hence, when randomization takes place and the third level, the design effect is given by  
   1 1 1n r n p      . 
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4.3 Randomize at Second Level without Interaction Effect  
4.3.1 Estimate  Var β  
Assume that for a center ith, the physicians are randomized such that  p physicians are in 
the treatment arm and (1 )p physicians are in the control arm. Thus, the number of patients 
allocated to the treatment arm is T1= Npn, and the number of patients allocated to the control 
arm is T2=(1 )Npn. Furthermore, assume that there is no interaction effect between treatment 
and center, i.e., any difference due to treatment is the same in every center. Under these 
assumptions, the correlation matrix remains the same form as described in 4.1.2: R
   1p n nr r         R I I J J pn  
The covariate matrix for a center iiX
th is a pn 2 matrix. The first column of this matrix 
contains all ones, whereas the second column contains ones in the first  p  rows, and zero in the 
remaining (1-
n
 )p  rows.  For example, consider a simple experiment in which each center in th 
has four physicians, and each physician has two patients. Suppose the physicians in each center 
are randomized such that the first two physicians are in the treatment group and the last two are 
in the control group. For a given center ith , the matrix Xi takes the following form: 
1 1
1 1
1 1
1 1
1 0
1 0
1 0
1 0
i
              
X  
The robust variance estimator of  N β β  is 
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
1
1
1
lim
N
N i
N


 
      Ti iX V X  
   12 1lim TT iN N N i


    X R X  
 12 1T
T i i     X R X    
 Var   is the right lower corner element of the above variance-covariance matrix . 
 
4.3.2 Derivation of  Ti i
-1X R X
Under the assumption of no interaction, the matrix 1R remain the same as derived in 4.1.2 
1 1
1 pn pn p n n
rI J I I J
r
 
 
               
R   
where  1 1n r n      and  
   1 1 1pn n r n p          . 
Expanding elements in the brackets, we have  
 1 1
1 p n n pn m n n
r rI I J J I I J
r
  
  
                      
R  
For simplification, let r a
   and b   
    1 1 1
1 p n n pn
I I aJ b na J
r
     R  
The matrix  is a 2 x 2 matrix with the following elements  Ti
-1X R Xi

T
i i
pn
pn pn pn

 
       
   
-1
-1 -1R R
X R X
-1 -1R R
all elements in  elements in first  columns of  
first  rows of elements in first  columns and first  rows of 
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Denote  as the sum of all elements in s 1R  and write  in terms of ,b , , and  s a n r
   2 2 2
2 2 3 2 2
1 1
1
1
1
s p n n a p n b na
r
pn pn a p n ab p n b
r
     
     
 
 
Denote t  as the sum of all elements that are in both first pn columns and first pn rows 
of .  1R
   2 2 2 2
2 2 3 2 2 2 2
1 1
1
1
t p n n a p n b na
r
p
1
n pn a p n ab p n b
 
   
     
     
 
Since is symmetric then 
r 
1R
T
i i
s s
s t


   -1X R X  .  
Add and subtract 2 2 2pn a pn  to the inside of the brackets of t , 
   
    
2 2 2 2 2 2 2 2 3 2 2 2 2
2 2 2 3 2 2
1
1
1 11 1
1 1r r    
t pn pn a pn a pn pn pn a p n ab p n b
r
pn na pn pn a p n ab p n b
       
  
         
         
 
ote that the terms in the second bracket equal  of all elements in . Also, note that 
 
1RN s, the sum
11 1 nr n nr n rna     
         
Substituting this into  we get t
  21pnt s  
   
Thus 
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  21Ti i
s s
pn
s s

  
        
  
-1X R X
 
 
And 
   
  2
1
1
1
T
i i
pn
s s
spn
s s
      
         
   
-1X R X
-  
The robust variance estimator of  N β β  is 
 12 1T
T i i     X R X  
The right lower corner element of the above variance-covariance matrix   is 
   
2
1
TVar
pn
      
Hence, when randomization takes place at the second level and assuming no interaction between 
center and treatment effects, the design effect is given by  1 1n r n     . 
 
4.4 Randomize at Second Level with Interaction Effect  
4.4.1 Estimate  Var β  
Assume that in each particular center ith, the physicians are randomized such that  p of 
them are in the treatment arm and (1 )p of them are in the control arm. Thus, the number of 
patients allocated to the treatment arm is T1= Npn, and the number of patients allocated to the 
control arm is T2=(1 )Npn. When the interaction between treatment and center exists, the 
robust variance estimator of N β β  can be obtained by computing  1Ti 1i     X V X . The 
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variance of the estimator  Var   is the right lower corner element of the above variance-
covariance matrix  .  
The distinction between randomization at second level with interaction and without 
interaction is that a new variance component representing the interaction between treatment and 
center is added to the model. The introduction of this interaction term changes the structure of 
the variance matrix V. 
 
4.4.2 The structure of  V
Denote this variance of the interaction as 2ct , the total variance is now 
2 2
T c
2 2
p e
2
ct        
2
ct  allows for the impact of treatment on the outcome measurement to vary across centers. 
Under mixed model theory, the structure of V can be written as follows: 
 block  2np cJ  , T
 
V U  , where: 
   2 2e n p np cI I J J  2tp n      U 
 
  
   2 2) (1 )e n p np ctJ J  2(1 p nI I         T  
To illustrate, suppose there are two centers, each center has three physicians and each physician 
has two patients. Furthermore, suppose randomization takes place at the physician level where 
the first two physicians are in treatment arm and the last physician is in control arm. For one 
center, the V  matrix is: 
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2 2 2 2 2 2
2 2 2 2 2 2
2 2 2 2 2 2
2 2 2 2 2 2
2 2 2 2 2 2
2 2 2 2 2 2
T c
T c
T c
T c c
c c c c T
c c c c T
c
c
c
     
     
     
     
     
     
           
V  
where 2 2c
2
ct     and 2 2 2c p 2ct      . 
There is no closed form for the right lower corner of the matrix  11Ti i
  X V X
 Var
 . Thus, 
we will use the general formula specified in equation (4.1) to compute  . 
 
4.5 Randomize at First Level without Interaction Effect  
4.5.1 Estimate  Var β  
For a the jth physician in the ith center, suppose the patients are randomized such that  n 
patients are in the treatment arm and (1 )n patients are in the control arm. Thus, the total 
number of patients allocated to the treatment arm is T1= Npn, and the number of patients 
allocated to the control arm is T2=(1 )Npn. In addition, assume that there is no interaction 
effect, i.e., the treatment works the same in every center–physician pair. Under these 
assumptions, the correlation matrix remains the same form as described in 4.1.2: R
   1p n nr r         R I I J J pn  
The covariate matrix for the iiX
th center is a pn×2 matrix. The first column of this matrix 
contains all ones, whereas the second column contains ones in the  pn rows corresponding to 
those patients allocated to the treatment group, and zero in the (1 )pn rows corresponding to 
those patients allocated to the control group.   
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For example, consider a simple case with two centers, each center has two physicians, 
and each physician has four patients: two patients are in the treatment group and two are in the 
control group. The  matrix for the iiX
th center is as follows: 
1 1
1 1
1 0
1 0
1 1
1 1
1 0
1 0
i
              
X  
The robust variance estimator of  N β β  is 

1
1
1
lim
N
N i
N


 
      Ti iX V X  
   12 1lim TT iN N N i


    X R X  
 12 1T
T i i     X R X    
 Var   is the right lower corner element of the above variance-covariance matrix .  
 
4.5.2 Derivation of  Ti i
-1X R X
Under the assumption of no interaction, the matrix 1R remain the same as derived in 4.1.2 
1 1
1 pn pn p n n
rI J I I J
r
 
 
               
R   
where  1 1n r n      and  
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   1 1 1pn n r n p          . 
Expanding elements in the brackets, we have  
 1 1
1 p n n pn m n n
r rI I J J I I J
r
  
  
                      
R  
For simplification, let r a
   and b   
    1 1 1
1 p n n pn
I I aJ b na J
r
     R  
The matrix  is a 2 x 2 matrix with the following elements  Ti
-1X R Xi
T
i i
       
   
-1
-1RX R X all elements in elements in treatment columns 
elements in treatment rows elements in both treatment columns and treatment rows
  
Let s  be the sum of all elements in 1R  and write s  in terms of a , , , and  b n r
   2 2 21 11s p n n a p n b nar        
Let t  be the sum of all elements appear in both treatment columns and treatment rows 
   2 2 2 2 21 11t p n n a p n b nar          
We then can write 
T
i i
s s
s t


     
-1X R X   
Thus 
  1 2 21Ti i t ss sst s 
      
 
-1X R X
 -  
The lower right element of the matrix  12 1TT i i     X R X is   2 2TVar t s   . Note that  
 67
 
        2 2 2 2 2 2 2 2 2 2 21 1 11t s p n n a p n b na p n n a p n b nar                 
   1
1
pn
r
    
Thus,      
2 1
1
T rVar
np
  
   
Therefore, when randomization takes place at the first level without interaction effect, the design 
effect is 1 . r
 
 
4.6 Randomize at First Level with Interaction Effect 
4.6.1 Estimate  Var β  
For a the jth physician in the ith center, suppose the patients are randomized such that  n 
patients are in the treatment arm and (1 )n patients are in the control arm. Thus, the total 
number of patients allocated to the treatment arm is T1= Npn, and the number of patients 
allocated to the control arm is T2=(1 )Npn. The robust variance estimator of  N β β  can 
be obtained by computing  Ti
1
i
1   X V X . The variance of the estimator  Var   is the right 
lower corner element of the above variance-covariance matrix  .  
We consider two different scenarios where the interaction effects might be found: (1) 
interaction between treatment and level three and (2) interaction between treatment and level 
two. 
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4.6.2 The Structure of  with Treatment × Level Three Interaction V
The first scenario considers the situation where the treatment effect varies across different 
centers. Denote the variance of the interaction as 2ct , the total variance is now given by: 
2 2 2 2
T c p e
2
ct         
Under mixed model theory, the structure of V can be written as follows: 
p p pI J I     V U T T  where  
          2 2 2 2 2(1 ) (1 ),n e n ct n e n ct n c pblock I J I J J    2              U    
      2 2(1 ),n ct n ct n cblock J J J  2   T  
To illustrate, consider the ith center with two physicians, each physician has four patients. 
Suppose the patients are randomized equally to the two treatment groups, the V matrix takes the 
following form:  
2 2
2 2
2 2 2
2 2 2
2 2 2
2 2 2
2 2 2
2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
T c
T c
T c c
T c c
c c T
c c T
c c T
c c T
2
2
c
c
       
       
       
       
       
       
       
       

               
V  
Where 2 2c p
2     , 2 2c 2ct    , and  2 2 2c p 2ct      . 
 There is no closed form for the right lower corner of the matrix  11Ti i
  X V X
 Var
 . Thus, 
we will use the general formula specified in equation (4.1) to compute  . 
 69
 
4.6.3 The Structure of with Treatment × Level Two Interaction V
The second scenario considers the situation where the treatment effect varies across different 
physicians. Denote the variance of the interaction as 2pt , the total variance is now 
2 2 2 2
T c p e
2
pt         
Under mixed model theory, the structure of V can be written as follows: 
p p pI J I     V U T T  where  
         2 2 2 2 2(1 ) (1 ),n e n pt n e n pt n c pblock I J I J J    2              U    
 2n cJ T  
To illustrate the above structure, consider center ith with two physicians, each physician has four 
patients. Suppose the patients are randomized equally to the two treatment groups, the V matrix 
takes the following form:  
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2 2 2
2 2 2
2 2 2
2 2 2
2 2 2
2 2 2
2 2
2 2 2
2 2 2
T c c c c
T c c c c
T c c c c
T c c c c
c c c c T
c c c c T
c c c c T
c c c c T
       
       
       
       
       
       
       
       

              
V
2
2
p
  
where 2 2c     and 2 2 2c p 2pt      .  
There is no closed form for the right lower corner of the matrix  11Ti i
  X V X
 Var
 . Thus, 
we will use the general formula specified in equation (4.1) to compute  . 
 
 70
 
Chapter 5 
Power and Sample Size for Binary Outcome 
 
 
In Chapter 4, we presented power and sample size formulas for three-level designs with 
continuous and normally distributed outcomes. In practice, however, it is very common to 
encounter experiments with correlated binary data. For example, consider a three-level design 
medical trial in which patients are selected within physicians, and physicians are selected within 
centers. Suppose the outcome is the presence or absence of a disease. The data from such study 
are binary and are correlated in a twofold nested fashion: measurements on patients are 
correlated within the same physicians, which in turn correlated within centers.  
Earlier, when working continuous Gaussian data, we derived the variance formulas for 
the estimated treatment effect based on linear mixed model theory. However, the vector of the 
expected means in binary outcome is typically not modeled as a linear function of the 
parameters. Thus, modification to the presented formulas for continuous data is required in order 
to answer the same power and sample size questions for binary data.  
Details of the modification will be provided in this chapter. First we will explain how 
generalize linear mixed models can be applied to derive the power and sample size functions for 
binary outcome. Next, we will show how the variance of the treatment difference will be 
computed in light of this approach. 
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5.1 Generalized Linear Mixed Models (GLMM) Approach 
5.1.1 Basic Model 
Consider a three-level CRT design in which patients are nested within physicians and physicians 
in turn are nested within centers. Denote the binary outcome variable from the ith center, jth 
physician, and kth patient as ijky . Let N be the total number of centers, p be the number of 
physicians in each center, and n be the number of patients visiting each physician (balanced 
design). The total sample size is T=Npn. 
The Generalized Linear Mixed Model is based on extending the fixed effect Generalized 
Linear Model by including the random effects. The model takes the following form: 
      1 1E g g   Y | γ Xβ Zγ η μ   
  g  μ Xβ Zγ   
where: 
 Y is the (T x 1) vector of the observed data 
 μ  is the vector of the expected means of Y 
 g(.) is a differentiable monotonic link function 
 X is a (T × m) fixed effects design matrix 
 β is a (m × 1) vector of regression coefficients for the fixed effects 
 Z is a (T × q) random effects design matrix.     
 γ is the (q×1) vector of random effects,  Nγ ~ 0,G  
 η  is the linear predictor, that is,  η Xβ Zγ . 
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Following GLMM theory, the variance of the observations conditional on the random 
effects can be written as: 
 Var Y | γ AB  
where  idiag aA  and     1'' gdiag b       
η
B η   . (See Chapter 3 for more details.) 
The unconditional variance takes the form: 
      Var Var  V Y μ AB  
V is not easy to specify because in the binary case μ  is not a linear function of β . 
Solutions for GLMM depend on the form of the likelihood function. In many cases, it is 
difficult to maximize this function since it involves T integrals over the q dimensional random 
effects. Hence, techniques of numerical approximation are required to solve the problem.  
 
5.1.2 Pseudo-likelihood Method 
 In order to derive the general form of the variance matrix V, we consider the application 
of pseudo-likelihood, a linearization method that was tested and implemented in the SAS PROC 
GLIMMIX procedure. Pseudo-likelihood maximizes the quasi-likelihood by iteratively 
analyzing a linearized pseudo variable. The term “pseudo” is used because the likelihood 
function maximized is a function of a pseudo variable, not of the original data. Here, the pseudo 
variable is based on a first-order Taylor series expansion for  g Y  about μ , which yields: 
   
 
1
1
g 

  
   
z μ Y μ B
Xβ Zγ Y μ B      
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This new model can be viewed as a linear mixed model with the new pseudo-observation 
z and the new random error term   1Y μ B . The variance of z can be formulated as (Brown 
and Prescott, 2006): 
 1 1T   zV ZGZ B AB B   
1T  zV ZGZ B A      
The variance of this linear mixed pseudo model will be used to derive the sample size and 
power formulas for binary outcomes. 
To specify  we need two pieces of information. The first piece  relates to the 
random effects in the model. As we will see in some explicit examples presented in the next 
sections, the components of consist of: (1) the between level two and within centers 
variance
zV
TZGZ
TZGZ
2
p , (2) the between level three variance 2c , and (3) the variance of the interaction terms 
when the interaction effect exists. The structure of  depends on which level randomization 
takes place. The process of deriving for the binary response is the same with that of the 
continuous response.  
TZGZ
TZGZ
The second piece  refers to the within physicians and between patients variance of 
the first level measures. Unlike the case of continuous outcomes, this variance is now a function 
of the binary proportion and is not independent from the mean. Letting 
1B A
 be the probability of 
“success” or the probability of observing a specific outcome and applying the logit link function, 
it can be seen from Section 5.1.1 that A is simply an identity matrix and is a diagonal matrix 
with elements of 
-1B
 
1
1  . We will see explicit examples of this in the next few sections. 
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Getting back to the three-level study design where the observed outcomes from the ith 
center, jth physician, and kth patient are binary variables ijky , suppose the interest is to test the 
difference between the two treatment effects. Let the probability of an event in the treatment 
group be t and in the control group be c . The marginal distributions of  and the 
corresponding mean and variances are as follow 
ijky
 ~ijk ty Bernoulli  when ijky  is in the treatment group 
 
   
|
1
ijk ijk t
ijk t t
E y x
Var y

 

   
 ~ijk cy Bernoulli  when ijky is in the control group 
 
   
|
1
ijk ijk c
ijk c c
E y x
Var y

 

   
Assuming the treatment effects are fixed and the model has no other covariates, i.e. m=2 and 
 0 , T β . Under logit model we can write 
 
 0 0
exp
1 expc
    
 
 0 0
exp
1 expt
   
    
Thus, clog log
1 1
t
t c
  
        

, which is the log odds ratio of the corresponding response 
probabilities.  
The hypothesis of   
:
:
t c
t c
 
 


0
0
H
H
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is now equivalent to     
: 0
: 0
and
b



 
0
A
H
H
 
Once the structures of  and of  are defined, the sample size and power estimates 
depend on the variance estimates of the fixed effects, which can be found by 
iZV iX
  11
1
N
i
i
Var



     Ti Z iβ X V X  
The asymptotic variance of  N    is determined by the right lower corner element 
of the estimated variance-covariance matrix    Var N    β β .  
The power to detect a difference of size  with a two-sided type I error rate of d  can be 
obtained by 
   , /2, , /2,1 t tN Npower t d t dVar Var      
               
 

   
where ,tT   is the cumulative distribution function of the t-distribution with   degrees of freedom 
and / 2,t   is the 100 2 % percentile from the t-distribution with   degrees of freedom. The 
value of  depends on the analysis method and the level where randomization takes place. 
It can be seen from the above equation that the most important step to determine power is 
the computation of the term  Var  , which is the lower right hand corner of the estimated 
variance-covariance matrix . Since the structure of     Var N    β β depends on the study 
design, the next following sections are devoted to explain how to compute   in particular cases 
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for binary outcomes depending on which level random assignment is performed and whether or 
not an interaction is taken into account. 
 
5.2 Randomize at Third Level  
Assume that the total N centers are randomized such that  N centers are in the treatment 
arm and (1 )N centers are in the control arm. Thus, the number of patients allocated to the 
treatment arm is T1= Npn, and the number of patients allocated to the control arm is 
T2=(1 )Npn. Furthermore, let the probability of an event in the treatment group be t and in 
the control group be c .  
Since randomization occurs at the center level, the covariate matrix and the variance 
of the pseudo variable  depend on to which treatment group a particular center is allocated. 
Denote the covariate matrix   and the variance matrix of the pseudo variable for the i
iX
ZiV
iX ZiV
th 
center. The robust variance estimator of  N β β  is 

1
1
1
lim
N
iN i
N


 
      Ti Z iX V X  
        11 1lim 1t t t c c cN N N N         T TZ ZX V X X V X  
      11 11t t t c c c        T TZ ZX V X X V X  
If the ith center is randomized into the treatment group, we have 
 i t pn pn X X 1 ,1  
  2 2
1
1Zi Zt p n p n ct t
  
        
V V I I J J pn    
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If the ith center is randomized into the control group, we have 
 0i c pn pn X X 1 ,   
  2 2
1
1Zi Zc p n p n cc c
  
        
V V I I J J pn   
To illustrate, consider a simple experiment with two centers, each center has two 
physicians, and each physician has two patients. Suppose that the first center is randomized into 
the treatment group and the second center is randomized into the control group. Furthermore, 
denote the total variance for each treatment group as and  , then 2treat 2control
   2 2 2
1
1treat c p t t
         
 2 2 2
1
1control c p c c
         
The structure of  and for the first center (treatment) are iX iZV
1 1
1 1
1 1
1 1
t
      
X  2
p
t
     and 
2 2 2 2 2
2 2 2 2 2
2 2 2 2
2 2 2 2 2
treat c p c c
c p treat c c
Zt
c c treat c
c c c p trea
V
    
    
    
    
        
 
The structure of  and for the second center (control) are iX iZV
1 0
1 0
1 0
1 0
t
      
X  2
p
ol
     and 
2 2 2 2 2
2 2 2 2 2
2 2 2 2
2 2 2 2 2
control c p c c
c p control c c
Zc
c c control c
c c c p contr
V
    
    
    
    
        
 
The variance of the estimated treatment effect  Var   is the right lower corner element of the 
variance-covariance matrix        11 1t t c c c1t       T TZ ZX V X X V X   
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5.3 Randomize at Second Level without Interaction Effect 
Assume that for the ith center, the physicians are randomized such that  p of them are in 
the treatment arm and (1 )p of them are in the control arm. Thus, the number of patients 
allocated to the treatment arm is T1= Npn, and the number of patients allocated to the control 
arm is T2=(1 )Npn. Furthermore, let the binary proportion for the treatment group be t and 
for the control group be c and assume that there is no interaction effect between treatment and 
center, i.e., the treatment works the same in every center. 
Since randomization takes place at the second level, all ’s are the same and all ’s 
are the same across the N centers. Thus 
iX ZiV
  1 11 1
1
lim
N
i iN i
N
  
 
      T Ti Z i i Z iX V X X V X  
In this study design, the covariate matrix for the iiX
th center is a pn x2 matrix. The first 
column of this matrix contains all ones, whereas the second column contains ones in the first 
 pn rows, and zero in the remaining (1 )pn rows. The structure of can be written as ZiV
   2, np cblock J  ZiV A B , where 
   211p nt tI I J  
      
A n p  
     21 11 n n pp c cI I  
      
B J  
For example, consider a simple experiment in which the ith center has two physicians, and 
each physician has two patients. Suppose the first physician in the center is randomized into the 
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treatment group and the second physician is randomized into the control group. The structures of  
Xi  and for  this particular center iZiV
th take the following form 
1 1
1 1
1 0
1 0
i
      
X  2
p
    and  
2 2 2 2 2
2 2 2 2 2
2 2 2 2
co
2 2 2 2 2
treat c p c c
c p treat c c
c c ntrol c
c c c p control
    
    
    
    
        
ZiV  
where    2 2 2
1
1treat c p t t
         and  
 2 2 2
1
1control c p c c
         
 
5.4 Randomize at Second Level with Interaction Effect 
The distinction between randomization at second level with interaction and without 
interaction is that a new variance term representing the interaction between treatment and center 
need to be added to the model. Although the covariate matrix  defined in Section 5.2 remains 
to be the same, the existence of the interaction term cause some changes in the structure of the 
variance matrix . Denote the variance of the interaction as 
iX
2
ctZiV  , now takes the following 
form 
ZiV
   2, np cblock J  ZiV A B  , where 
    2 211p n n pt tI I J J  pn ct  
       
A  
         2 21 111 n n p ctp nc cI I J J p   
       
B  
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For example, consider a simple experiment in which the ith center has four physicians, 
and each physician has two patients. Suppose the first two physicians in the center are 
randomized into the treatment group and the next two physicians are randomized into the control 
group. Furthermore, suppose that the treatment effect varies across different centers, then for the 
ith center, we  can write  
1 1
1 1
1 1
1 1
1 0
1 0
1 0
1 0
i
              
X
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       
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       
       
       
       
     
V
2 2 2
control 
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Where 
 2 2 2 2
1
1treat c p ct t t
            
 2 2 2 2
1
1control c p ct c c
           
2 2
c c
2
t     
2 2 2
c p
2
ct       
 81
 
5.5 Randomize at First Level without Interaction Effect 
Assume that there is no interaction effect, i.e., the treatment works the same in every 
center and every physician. For a the jth physician in the ith center, suppose the patients are 
randomized such that  n patients are in the treatment arm and (1 )n patients are in the control 
arm. Thus, the total number of patients allocated to the treatment arm is T1= Npn, and the 
number of patients allocated to the control arm is T2=(1 )Npn. Furthermore, let the probability 
of an event in the treatment group be t and in the control group be c . Since randomization 
takes place at the first level,  and are the same across all centers. Thus iX ZiV
  1 11 1
1
lim
N
i iN i
N
  
 
      T Ti Z i i Z iX V X X V X  
The covariate matrix for the iiX
th center is a pn x2 matrix. The first column of this matrix 
contains all ones, whereas the second column contains ones in the  pn rows corresponding to 
those patients allocated to the treatment group, and zero in the (1 )pn rows corresponding to 
those patients allocated to the control group.   
The structure of can be written as ZiV
   2 2,p n c p pblock           ZiV I A B J J C I p C , where 
 
1
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 
     
A I  
   1
1
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  
     
B I  
 2n cC J  
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For example, suppose the ith center has two physicians and each physician has four 
patients. Suppose the first two patients are randomized into the treatment group and the next two 
patients are randomized into the control group. Then, for the ith center, we have 
1 1
1 1
1 0
1 0
1 1
1 1
1 0
1 0
i
              
X  
And the structure of is ZiV
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2
treat c c c c
treat c c c c
control c c c c
control c c c c
Zi
c c c c treat
c c c c treat
c c c c control
c c c c
       
       
       
       
       
       
       
     
V
2 2 2
control 
             
 
Where  
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5.6 Randomize at First Level with Interaction Effect 
We consider two different scenarios where the interaction effects might be found: (1) 
interaction between treatment and level three and (2) interaction between treatment and level 
two. 
 
5.6.1 The Structure of  with Treatment × Level Three Interaction ziV
Under the same randomization scheme, what if the treatment effect varies across 
different centers? In this situation, an interaction effect between treatment and center should be 
taken into account. 
Since the presence of the interaction effect does not lead to any change on covariate 
matrix , the difference in the computation of iX   relies solely on the modification in the 
structure of . This modification can be done by introducing a new variance term denoted by ZiV
2
ct . V now takes the following structure: Zi
   2 2,p n c p pblock           ZiV I A B J J C I p C  
   211 n n ctt t    
     
A I J  
       21 111 ctn nc c      
     
B I J  
        2 21,n ct ct n cnblock   2   C J J J  
For a simple example with two centers, each center has two physicians, and each 
physician has four patients: two are in the treatment group and two are in the control group. We 
then have: 
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Where  
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5.6.2 The Structure of  with Treatment × Level Two Interaction ziV
Now, let us consider another scenario when the treatment effect varies across different 
physicians. In this scenario, an interaction effect between treatment and physician is required. 
Again, the presence of the interaction effect does not lead to any change on covariate 
matrix  and the difference in the computation of iX   only depends on the modification in the 
structure of . This modification is done by the introduction of the variance of the interaction 
term reflecting the interaction between physician and treatment 
ZiV
2
pt . now takes the following 
structure: 
ZiV
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   2 2,p n c p pblock           ZiV I A B J J C I p C  
   211 n n pt t   t 
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     
B I J  
 2n cC J  
For a simple example with two centers, each center has two physicians, and each 
physician has four patients: two are in the treatment group and two are in the control group. We 
then have  
1 1
1 1
1 0
1 0
1 1
1 1
1 0
1 0
i
            
X   and   
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2
2 2 2 2 2
treat c c c c
treat c c c c
control c c c c
control c c c c
c c c c treat
c c c c treat
c c c c control
c c c c
       
       
       
       
       
       
       
     
ZiV
2 2 2
control 
             
where 
 2 2 2 2
1
1treat c p pt t t
           
 2 2 2 2
1
1control c p pt c c
           
2 2
c p
2     
2 2 2
c p
2
pt       
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Chapter 6 
Simulation Study 
 
 
As presented in Chapters 4 and 5, our power and sample size calculations are based on 
asymptotic theory, particularly the derivation of the variance of the treatment effect. It is 
reasonable to suspect that a minor variation in the approach proposed for the intervention 
evaluation can cause substantial difference in power and sample size estimates. To assess the 
accuracy of our methods, we conducted a simulation study designed to verify sample size and 
power calculations. The results showed that the theoretical power estimates from our formulas 
are consistent to the empirical power computed from the simulated data. 
This chapter explains the process that was used to generate the data for the different 
designs presented in Chapter 4 and Chapter 5. The simulation results will be then presented and 
discussed. 
 
6.1 Simulation Design 
We simulated data for cluster randomized trials with three-level design under the 
assumption of balanced sample sizes, i.e. the numbers of subjects per each cluster are equal 
across all clusters. For example, if the trial includes patient nested within physician and 
physician nested within center, then the numbers of patients for each physician are the same and 
the numbers of physicians for each center are the same across all centers. In all the settings, we 
assumed a completely randomized design that involved two arms: a treatment arm and a control 
arm. We considered six different scenarios for each type of outcomes: continuous and binary. 
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The six scenarios are dictated by which level the allocation of treatment takes place and whether 
there is an interaction effect or not. They include (1) randomize at level three, (2) randomize at 
level two without interaction, (3) randomize at level two with interaction, (4) randomize at level 
one without interaction, (5) randomize at level one with interaction between treatment and level 
three, and (6) randomize at level one with interaction between treatment and level two. 
To verify the accuracy of the derived power and sample size functions, we compared the 
theoretical power given by our proposed formulas (denote by ) to the empirical power given 
by the simulated data (denote by ) . The theoretical power was computed using SAS PROC 
IML, which specifies the forms of the variance matrices and yields the power based on our 
theory. The empirical power was obtained by fitting the simulated data sets with linear mixed 
models using SAS PROC MIXED for continuous outcome, and generalized linear mixed models 
using SAS PROC GLIMMIX for binary outcome. The p-values for testing the null hypothesis of 
no treatment effect were retained after each the model fitting process. Denote the p-value by 


rp for the r
th repetition of the simulated data with a total of R repetitions, the empirical power 
can be calculated by 

 R r
r
p
R



  
For comparison, we estimated the 95% confidence intervals for the empirical power and 
recorded the number of iterations where the confidence interval covered the theoretical power. In 
addition, the absolute difference between the two values of powers was also computed in order to 
assess the discrepancy between the theoretical power and the empirical power.  The simulation 
methods are slightly different between the continuous outcome and the binary outcome. We will 
discuss the simulation processes for the two types of outcomes separately. 
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6.2 Simulation for Continuous Data 
For continuous outcomes, the following parameters were pre-specified: 
 The desired theoretical power   
 The two-sided significance level   
 The proportion of allocation into treatment   
 The variances between level three 2c , the variance between level two 2p , and the 
variance between level one 2e . 
 The variances of the interaction effect between treatment and level three 2ct  or between 
treatment and level two 2pt  (if the interaction at these levels exist). 
The following parameters were allowed to vary 
 The intervention effect trt  and control effect ctrl  
 The sample sizes in each level c, p, and n 
 
Our simulation programs were designed in such a way that the results can be collected 
for any chosen combination of the above parameters. In this report, we chose to fix the desired 
power  and 0.75 0.05  . However, these two parameters can be set at different values. 
To chose the values for the ICC, we looked at  recent publications on sample size 
estimation for three-level designs in healthcare experiments. Our review suggested that the 
intraclass correlation on level three (  ) is much smaller than that of level two ( ). For example, 
in a recent study conducted by Heo and Leon (2009), the researchers examined a combination of 
r
0.01, 0.05, 0.10   and . Taking the first combination of 0.4, 0.6r  0.5,  and , together r
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with a total variance of , our pre-specified variance parameters were , 
, , , .  
2 1T 
0.05
2 0.01c 
2 0.39p  2 0.60e  2ct  2 0.02pt 
The differences between intervention and control effects were derived from the 
corresponding sample sizes and the desired power of 0.75 from our theoretical formulas. Since 
the power is set at a fixed value and the variances are also set at the pre-specified values, the 
difference in treatment effect is a function of the variances and the selected power. 
The sample sizes in each level were varied amongst large, medium, and small sizes. 
These sample sizes again were chosen based on common sample sizes reported from the 
literature of CRT. More specifically, we considered the following: 
 
 Sample sizes for level three c=10 , 20, 30  
 Sample sizes for level two: p=4, 8, 12 
 Sample sizes for level one n=10, 20, 30 
 
This 3×3×3 factorial design yielded a total of 27 combinations for each set of parameters. 
In order to allow for a workable compromise between the magin of error and the number of 
repetitions, we chose a margin of error of 0.035. With this, we arrived at a total number of 
repetitions of 784 data sets for each combination. Thus, altogether we had 21,168 sets of data 
across the six different scenarios with continuous outcomes.  
For each different scenario, we performed different steps to simulate the corresponding 
data sets. Details of the steps as well as the simulation algorithms will be described in the next 
paragraphs. 
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Case 1: Randomization at Level Three—Continuous Outcome 
 Generate 2c~ ,i trtX N    independently, where i=1,2,…, c for the treatment  
 Generate 2c~ ,i ctrlX N    independently, where i= 1c  , 2,c  .., c for the control 
 For each iX , generate  2pY N X~ ,j i   independently, where j=1,2,…, p 
 For each jY , generate  2e~ ,k jZ N Y   independently, where k=1,2,…,n 
 
The simulation algorithm for case 1 is illustrated in Figure 6.2.1  
 
Figure 6.2.1: Simulation Algorithm 
Randomize at Level Three—Continuous Outcome 
 
 
 2~ ,ctrl ctrl cX N  
 
 2~ ,trt trt cX N    
Level 2 
Level 1 
 2~ ,ctrl ctrl pY N X   
 2~ ,ctrl ctrl eZ N Y 
 2~ ,trt trt pY N X   
Level 3 
ControlTreat 
 2~ ,trt trt eZ N Y    
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Case 2: Randomize at  Level Two without Interaction—Continuous Outcome 
 Generate  2~ 0,i cX N   
 For each iX , generate  2~j i trtX , pY N    independently, where j=1,2,…, p  for the 
treatment group and generate  2,ctrl pY N~j iX    independently,  where j= 1 p  , 
2,p  …, p in the control group 
 For each jY , generate  2e~ ,k jZ N Y   independently,  where k=1,2,…,n 
 
The simulation algorithm for the case 2 is described in Figure 6.2.2 
 
Figure 6.2.2: Simulation Algorithm  
Randomize at Level Two without Interaction –Continuous Outcome 
 
Level 3  2~ 0, cX N 
Treat 
Level 2 
Level 1 
 
Control  2~ ,ctrl ctrl pY N X  
 2~ ,ctrl ctrl eZ N Y 
 2~ ,trt trt pY N X  
 2~ ,trt trt eZ N Y   
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Case 3: Randomization at Level Two with Interaction—Continuous Outcome 
 Generate  2c~ 0,iX N   independently 
 Generate the treatment effects  2~ ,T trtN ct   for the treatment group and 
2ct~ ,C ctrlN    for the control group.  
 For each iX , generate  2~j i TX , pY N    independently , where j=1,2,…, p  for the 
treatment group and generate  2,C pY N~j iX    independently, where j= 1 p  , 
2,p  …, p for the control group 
 For each jY , generate  2~ ,k jZ N Y e  independently,  where k=1,2,…,n 
The simulation algorithm for the case 3 is described in Figure 6.2.3 
 
Figure 6.2.3: Simulation Algorithm  
Randomize at Level Two with Interaction –Continuous Outcome 
 
 
Level 3  2~ 0, cX N 
Level 2 
Level 1 
Treat Control  2~ ,ctrl T pY N X    
 2~ ,ctrl ctrl eZ N Y   
 2~ ,trt T pY N X    
 2~ ,trt trt eZ N Y   
 2~ ,T trtN
Interaction Interaction
 2~ ,C ctrlNct    ct    
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Case 4: Randomize at Level One without Interaction—Continuous Outcome 
 Generate  2~ 0,i cX N   
 For each iX , generate  2pY N X~ ,j i   independently, where j=1,2,…,p 
 For each jY , generate  2~k j trtZ N Y , e   independently, where k=1,2,…, n  for the 
treatment group and generate  2~ ,ctrlk jZ N Y e   independently, where k= 1n  , 
2,n  …, n in the control group 
 
The simulation algorithm for the case 4 is described in Figure 6.2.4 
 
Figure 6.2.4: Simulation Algorithm  
Randomize at Level One without Interaction –Continuous Outcome 
 
Level 3  2~ 0, cX N   
Level 2  2~ , pY N X 
Treat 
Level 1 
 
Control 2~ ,trt trt eZ N Y     2~ ,ctrl ctrl eZ N Y    
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Case 5: Randomize at Level One with  Treatment ×Level Three—Continuous Outcome 
 Generate  2c~ 0,iX N   independently 
 Generate the treatment effects  2~ ,T trtN ct   for the treatment group and 
2ct~ ,C ctrlN    for the control group.  
 For each iX , generate  2pY N X~ ,j i   independently, where j=1,2,…,p 
 For each jY , generate  2~ ,k j TZ N Y e   independently,  where k=1,2,…, n  for the 
treatment group and  2~ ,k j C eZ N Y    independently, where k= 1n  , 2,n  …, n 
in the control group 
The simulation algorithm for the case 5 is described in Figure 6.2.5 
 
Figure 6.2.5: Simulation Algorithm  
Randomize at Level One with Treatment × Level Three –Continuous Outcome 
 
Level 3  2~ ,T trtN  2~ ,C ctrlN 2~ 0, cX N 
 
Level 2  2~ , pY N X 
Level 1 
Treat Control  2~ ,ctrl C eZ N Y  
 
 2~ ,trt T eZ N Y    
ct    ct  
Interaction Interaction
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Case 6: Randomize at Level One with Treatment ×Level Two—Continuous Outcome 
 Generate  2c~ 0,iX N   independently 
 For each iX , generate  2pY N X~ ,j i   independently, where j=1,2,…,p 
 Generate the treatment effects  2~ ,T trtN pt   for the treatment group and 
2pt~ ,C ctrlN    for the control group.  
 For each jY , generate  2~ ,k j TZ N Y e   independently, where k=1,2,…, n  for the 
treatment group and generate  2, e~Z Nk j CY   independently, where k= 1n  , 
2,n  …, n in the control group 
The simulation algorithm for the case 6 is described in Figure 6.2.6 
 
Figure 6.2.6: Simulation Algorithm  
Randomize at Level One with Treatment × Level Two –Continuous Outcome 
Level 3  2~ 0, cX N 
Level 2  2~ ,T trtN  2~ ,C ctrlN 2~ , pY N X pt    pt  
 
 
Treat Control 
 2~ ,trt T eZ N Y    2~ ,ctrl C eZ N Y  Level 1   
 
Interaction Interaction
 96
 
6.3 Simulation for Binary Data 
Similar to the continuous cases, the following parameters were pre-specified for binary data: 
 The desired theoretical power   
 The two-sided significance level   
 The proportion of allocation into treatment   
 The variances between level three 2c , the variance between level two 2p  
 The variances of the interaction effect between treatment and level three 2ct  or between 
treatment and level two 2pt  (if the interaction at these levels exist). 
The following parameters were allowed to vary 
 The probability of an event t in the treatment group and c in the control group 
 The sample sizes in each level c, p, and n 
Again, we chose to fix the desired power 0.75  and 0.05  . The pre-specified 
variance parameters were , , , . Setting the probability 
of the event in the control group as 
2 0.01c  2 0.39p 
0.7c
2 0.05ct   2pt  0.02
  , the differences between intervention and control 
probabilities were computed from the corresponding sample sizes and the desired power of 0.75 
given by the theoretical formulas. The sample sizes in each level were varied amongst large, 
medium, and small sizes. We considered c=10, 20, 30 ; p=4, 8, 12; and n=10, 20, 30, which 
yielded a total of 27 combinations for each set of parameters. For a margin of error of 0.035, we 
arrived at a total number of repetitions of 784 data sets for each combination. Thus, altogether 
we had 21,168 sets of data for across the six different scenarios with binary outcome.  
Following the general linear mixed models approach, we assumed the random effects in 
level three and level two are normally (Gaussian) distributed. To generate binary data, we 
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followed a model that linearly relates level one to the higher level cluster effects by way of the 
logit of the probabilities. Details for the six cases are described below. 
 
Case 7: Randomize at Level Three—Binary Outcome 
 Generate 2c~ ,i trtX N    independently, where i=1,2,…, c for the treatment group 
and  2~ ,i ctrl cX N    independently, where i= 1c  , 2,c  …, c for the control group 
 For each iX , generate  2pY N X~ ,j i   independently,  where j=1,2,…, p 
 For each jY , compute    and generate  j1/ 1 jYjp e  ~kZ Bernoulli p  independently,  
where k=1,2,…,n 
The simulation algorithm for case 7 is illustrated in Figure 6.3.1  
 
Figure 6.3.1: Simulation Algorithm 
Randomize at Level Three—Binary Outcome 
 2~ ,ctrl ctrl cX N     2~ ,trt trt cX N    Level 3 
Level 2 
Level 1 
 2~ ,ctrl ctrl pY N X    2~ ,trt trt pY N X   
 
 
1/ 1
~
trtY
trt
trt trt
p e
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 
 
 
 
1/ 1
~
ctrlY
ctrl
ctrl ctrl
p e
Z Bernoulli p
 
 
ControlTreat 
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Case 8: Randomize at Level Two without Interaction—Binary Outcome 
 Generate  2c~ 0,iX N   independently 
 For each iX , generate  2~j i trtX , pY N    independently, where j=1,2,…, p  for the 
treatment group and generate  2,ctrl pY N~j iX    independently, where j= 1 p  , 
2,p  …, p in the control group 
 For each jY , compute    and generate  j1/ 1 jYjp e  ~kZ Bernoulli p  independently, 
where  k=1,2,…,n 
The simulation algorithm for case 8 is described in Figure 6.3.2 
 
Figure 6.3.2: Simulation Algorithm  
Randomize at Level 2 without Interaction –Binary Outcome 
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 
 
 
 
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 
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Case 9: Randomiz evel Two with Interactioe at L n—Binary Outcome 
 Generate  ~ 0,i cX N 2  independentl
the treatment effects 
y 
 Generate  2trtN~ ,T ct   for the treatment group and 
 2~ ,C ctrl ctN    for th oup.  
 For each i
e control gr
X , generate  2i T~jY N X , p   independently,  where j=1,2,…, p  for the 
treatment group and generate  2~ ,i CjY pN X    independently,  where j= 1p  , 
2,p  …, p for the co oup 
 For each jY , compute 
ntrol gr
 1/ 1 jYjp e   and generate  ~k jZ Bernoulli p  independently, 
he simulation algorithm for the case 9 is described in Figure 6.3.3 
Randomize at Level 2 w ction –Binary Outcome
 
where k=1,2,…,n 
T
 
Figure 6.3.3: Simulation Algorithm  
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 
 
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ctrlY
ctrl
ctrl ctrl
p e
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 
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 
 
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 2~ ,ctrl ctN    
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Case 10: Random Level One without Interaize at ction—Binary Outcome 
 Generate  ~ 0,i cX N 2  independently 
 pY N 2~ ,j X  For each iX , generate  independently,  where j=1 2,…,p,  
, compute  1/ 1 j trttrtp e   and Y   For each Yj  1/ 1 j ctrlctrlp e   
 Generate ~trt
Y  
 trtZ Bern ndependently, where k=1,2,…, noulli p  i   for the treatment 
group and generate  ctrl~trtZ Bernoulli p  independently, where k= n 1  , 2,n  …, n 
he simulation algorithm for case 10 is described in Figure 6.3.4 
andomize at Level 1 without Interaction –Binary Outcome 
 
 
in the control group. 
T
 
Figure 6.3.4: Simulation Algorithm  
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Case 11: Random Level One with Treatmenize at t ×Level Three—Binary Outcome 
 Generate  ~ 0,i cX N 2  independentl
the treatment effects 
y 
 Generate  2trtN~ ,T ct   for the treatment group and 
 2~ ,C ctrl ctN    for the control group.  
 p2~ ,jY N X For each iX , generate   independently, where j=1,2,…,p 
, compute  1/ 1 j Ttrtp e   and Y   For each Yj  1/ 1 j Cctrlp e   
 Generate  trt
Y  
~trtZ Bernoulli p  independently,  where k=1,2,…, n  for the treatment 
group and trt  ~ ctrlZ Bernoulli p  independently,  where k= 1n  , 2,n  …, n in the 
he simulation algorithm for case 11 is described in Figure 6.3.5 
andomize at Level One with Treatment × Level Three –Binary Outcome 
 
 
control group 
T
 
Figure 6.3.5: Simulation Algorithm  
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Interaction Interaction 
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Case 12: Randomize at Level One with Treatment ×Level Two—Binary Outcome 
 folloWe performed the wing: 
 Generate  ~ 0,i cX N 2  independently 
 For each iX , generate  ~ ,j pY N X 2  ently,  where j=1,2,…,p 
the treatment effects 
independ
 Generate  2,trtN~T pt   for the treatment group and 
 2~ ,C ctrl ptN    for t group.  he control 
, compute  1/ 1 j Ttrtp e   and Y   For each Yj  1/ 1 j Cctrlp e   
 Generate  trt
Y  
~trtZ Bernoulli p  independently, where k=1,2,…, n  for the treatment 
group and trt  ~ ctrlZ Bernoulli p  independently,  where k= 1n  , 2,n  …, n in the 
described in Figure 6.3.6 
andomize at Level One with Treatment × Level Two –Binary Outcome 
 
 
control group 
The simulation algorithm for case 12 is 
Figure 6.3.6: Simulation Algorithm  
R
Level 3  2~ 0, cX N 
Level 2  2~ , pY N X 
Level 1 
Treat Control  
 
1/ 1
~
CY
ctrl
ctrl ctrl
p e
Z Bernoulli p
  
   
1/ 1
~
TY
trt
trt trt
p e
Z Bernoulli p
  
 
 2~ ,T trtN pt    
Interaction Interaction 
 2~ ,C ctrlN pt    
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6.4 Sim
d by the simulation experiment. To answer this question, we examine the following 
6.4.1 S
 the 
empirical powers where results are combined for the six scenarios for continuous outcome.  
.4.1: Su f tio  us O
Design 
os 
evel 3 
 
Level 
2 
evel 2 with 
Interacti
 
Level 1 el 1 with 
Treat × L
3   
Level 1 with 
Treat× Lev
ulation Results 
The main question addressed by the simulation study was that given a set of parameters, 
how well does the power from the derived sample size formulas agree with the empirical power 
generate
results. 
imulation Results for Continuous Outcome  
Table 6.4.1 shows the mean, minimum, maximum, and the standard errors of
 
Table 6 mmary o Simula n Results for Continuo utcome 
scenari
L L
on 
Lev
evel el 2 
Mean 0.75 0.75 0.72 0.75 0.73 0.73
Min 0.67 0.70 0.65 0.67 0.68 0.69
Max 
SE 0.0065 0.0051 0.0061 0.0055 0.0042 0.0039
0.85 0.79 0.77 0.82 0.76 0.77
 
Tables B.1 to B.6 in Appendix B present in more detail the specified sample sizes for the 
three levels, the empirical power  , and the absolute differences between the empirical powers 
and the theoretical powers for the continuous case. These tables show that in most of the cases 
the values of theoretical power are consistent with those of the empirical power regardless of the 
sample 
underestimated, most would consider the difference negligible. The rational for this is that Proc 
size combination.  
It is noticed that in the cases with interaction, although the empirical powers were 
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MIXED tends to overestimate the interaction variance components, which in turn lowers the 
power because the estimated variance of the difference is larger.  
Overall, the results for continuous data showed that the empirical powers varied around 
the theoretical powers at all sample sizes combination. In all combinations of the sample sizes 
considered, the theoretical the powers were covered by the 95% confidence intervals of the 
empirical powers in 93.8% (152/162) of the cases. This result is consistent for cases with and 
without interaction. The absolute differences between the empirical powers and the theoretical 
power were fairly small, with an average of 0.025 (SE=0.0284). Thus, the results for continuous 
data indicate that the power based on our derived formulas is nearly identical to the empirical 
power based on the simulated data. 
 
6.4.2 Simulation Results for Binary Outcome 
Table 6.4.2 displays the mean, the minimum, and the maximum, and the standard errors 
of the empirical powers for all the six different scenarios for binary outcome. 
 
Table 6.4.2: Summary of Simulation Results for Binary Outcome 
Design 
scenarios 
Level 3 
 
Level 2 Level 2 with  
Interaction  
Level 
1 
Level 1 with 
Treat × Level 
3   
Level 1 with 
Treat× Level 2 
Mean 0.75 0.74 0.73 0.76 0.73 0.73
Min 0.70 0.66 0.65 0.68 0.66 0.70
Max 0.84 0.85 0.78 0.80 0.77 0.77
SE 0.066 0.0074 0.0056 0.0053 0.0052 0.0043
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Tables B.7 to B.12 in Appendix B present in more detail the specified sample sizes for 
the three levels, the empirical power , and the absolute differences between the empirical 
powers and the theoretical powers for the binary case.  
Similar to the continuous case, the empirical powers were lower than the theoretical 
powers in the cases with interaction. This is due to the overestimate of the interaction variance 
components caused by PROC GLIMMIX.  
Overall, the results for binary data showed that the empirical powers are consistent with 
the theoretical powers at all sample sizes combination. In combination of the sample sizes 
considered, the theoretical powers remain within the 95% confidence intervals of the empirical 
powers in 87.0% (141/162) of the cases. The absolute differences between the empirical powers 
and the theoretical powers were fairly small, with an average of 0.025 (SE=0.0202). Thus, the 
simulation results for binary data also indicate that the power based on our derived formulas is 
nearly identical to the empirical power based on the simulated data. 
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Chapter 7 
Application 
 
 
Up to this point, we have discussed the issues of sample size and power calculation for 
CRT with three-level designs. We derived the relevant formulas for important scenarios where 
random assignment takes place at different levels. However, these formulas are not easy to use 
since some are not straightforward and explicit. To make the connection between the theoretical 
methods and their practical applications, we composed a SAS program that allows the user to 
compute power and sample size using our methods. First, we will describe the basis of the 
program and its algorithm. Next, we will present a few hypothetical examples where the program 
can be used to answer practical power and sample size questions. 
 
7.1 The User-Interface Program 
To put theory into practice, we developed a macro program using the SAS software 
(version 9.2; SAS Institute Inc, Cary, North Carolina). The goals of the program are: 
(1) To compute sample size and power using the derived formulas.  
(2) To serve as a tool that enables users to input their own parameters and receive 
customized output.  
(3) To allow users to explore power and sample size results in different design 
scenarios. 
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The program consists of three sections. The first section uses SAS %WINDOW, which is 
part of the macro language included in the Base SAS system. The %WINDOW statement 
provides the functionality of prompting for user input, placing the input into macro variables,  
and resolving them to generate program code. Once defined, the macro variables remain in effect 
until the SAS session is terminated or until the user redefines them through additional input. In 
this program, the %WINDOW statement presents several groups of input fields. These groups 
include different design scenarios (depending on the user’s choices), instructions for the next 
steps, and warnings about an input error. 
The second section of the program consists of a series of macros, which are used to 
compute power or sample size for the six design settings for two types of outcomes, continuous 
and binary, as described in Chapter 4 and Chapter 5. Thus, altogether there are twelve different 
design scenarios. For each different design, four macros were written to compute (1) power, (2) 
sample size of level three, (3) sample size of level two, and (4) sample size of level one. The 
computations are carried out in SAS PROC IML based on the derived formulas. In addition, a 
few macros were composed to count the number of missing entries or to reset all macro variables 
once the users chose begin a new calculation. 
The third part of the program put everything together. This section called for the 
information provided by the first section, ran the calculation from the macros in the second 
section, and provided the results using the %DISPLAY statement. To allow for a variety of 
reporting capabilities, the program followed an algorithm that depended on the user’s input. A 
description of this algorithm is shown in Figure 7.1. 
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Figure 7.1: Algorithm for the User-Interface Program 
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Step 3 
 
Which of the following do you wish to 
compute? 
 Level 3 sample size 
 Level 2 sample size 
 Level 1 sample size 
 Power 
Step 2 
 
Please select the following designs 
(randomizing at): 
 Level three 
 Level two 
 Level one 
 Level two with interaction 
 Level one with interaction 
between treatment and level 3 
 Level one with interaction 
between treatment and level 2 
 
Step 1 
 
What is your main outcome? 
 Continuous 
 Binary 
Step 4 
 
Please enter the following parameters 
(User inputs) 
Error! Only select 
one option! 
Error! One option 
must be selected! 
Both were selected 
None was selected
None was selected 
More than two were 
selected
Error! One option 
must be selected! 
Error! Only select 
one option! 
None was selected 
Missing at least 
one parameter Error! Please fill in 
all the requested 
parameters  
More than one 
were selected
Error! One option 
must be selected! 
Error! Only select 
one option! 
RESULTS 
 
7.2 Application Example for Continuous Data 
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 To illustrate how power and sample size in a three-level study can be computed using our 
methods, we present a power analysis example with continuous data taken from a recent study. 
The example itself can be used as a template for other similar research designs. 
Consider the cluster randomized trial conducted by Calear et at. (2009). The study was 
designed to investigate the effect of an online, self-directed cognitive behavior program in 
preventing and reducing the symptoms of anxiety and depression in an adolescent school-based 
population. The program was based on cognitive behavior therapy. It consisted of five interactive 
modules with information, animated demonstration, quizzes and exercise. The goal of the 
program was to change dysfunctional thoughts, improve interpersonal relationship, and teach the 
students important life skills.  
The outcome variables of interest were anxiety and depressive symptoms. Both anxiety 
and depression quizzes were completed at the beginning and the end of the MoodGYM program. 
Anxiety was measured with the Revised Children’s Manifested Anxiety Scale, which consists of 
37-item self-report questionnaire. A total score was calculated by summing the “Yes” responses 
for the anxiety-related questions. Depressive symptoms were measured with the Center for 
Epidemiological Studies Depression Scale, which consists of 20 items. A total score was 
calculated by summing item scores and are assumed to have a continuous distribution. 
The authors computed a power analysis from a two-level standpoint with students nested 
within classrooms (school effect was not taken into account). Under this assumption, the 
reported sample size was approximately 15 classes of 30 for each treatment arm. The calculation 
was based on detecting a post-intervention effect size of 0.30, with a power of 0.90 and 
alpha=0.05. The ICC coefficient at the class level (between-classes variance divided by total 
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variance) was assumed to be 0.02 and the total variance was assumed to be 36 based on the 
report from the study.  
We will perform a power analysis for the aforementioned study under the three-level 
framework. To do this, we first assume that the schools were randomly sampled from a larger 
population of schools. In addition, we also need to select plausible values for the clustering effect 
at the school level since this information was missing in the paper. We follow the report from the 
National Assessment of Educational Progress, which suggested that with a three-level design 
(students are nested within classrooms and classrooms are nested within schools), the clustering 
effect at classroom level is approximately 2/3rds as large as the clustering effect at the school 
level (Konstantopoulos, 2008). Thus, given the classroom ICC of 0.02 in this study, we obtained 
an ICC of 0.03 for the school effect. This value represent the correlation between two students in 
the same school (and different classrooms).  
It follows that the variances at school level and classroom level can be determined by 
2 2 0.03 36 1.08c T        
2 2 0.02 36 0.72p Tr       
2 2 2 2 36 1.08 1.72 34.2e T c p           
Note that the authors defined 
2
2
c
T
   and 
2
2
p
T
r

 . With an effect size of 0.3, the 
difference measurement between the treatment and control groups is given by: 
2 0.3 36 1.8Td        
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Case 1: Randomize at Level One without Interaction 
Assume for each school the researchers plan to select 6 classrooms each with a class size 
of 30. Furthermore, the researchers will randomize all students equally into two study arms. The 
treatment effect is assumed to be the same across all schools (no interaction effect).  
We propose to compute sample sizes under the case of randomizing at level one without 
interaction using our methods. Given the above information, our first task is to compute the 
sample size of level three (number of schools). Following the algorithm in Figure 7.1, the steps 
to be taken are as follows: 
 Step 1: Continuous outcome 
 Step 2: Randomizing at level one  
 Step 3: Computing sample size at level three 
 Step 4: The parameters entered are 
o Proportion randomized to intervention arm 0.5  ,  
o Expected power  1 0. 09   
o Significance level 0.05   
o Sample size of level two p = 6 
o Sample size of level one n=30  
o Variance between schools 2 1.08c   
o Variance between classes 2 0.72p   
o Residual variance 2 34.2e   
o The treatment difference needed to detect 1.8d   
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Entering the above parameters in the program, we obtain the sample size of c=3 for level 
three. Thus, given the class size of 30 and 6 classrooms per school, we will need 3 schools to 
enroll in the study in order to achieve a power of 90% with 0.05  . 
What if the number of classrooms per school is larger or smaller? Let us go back to step 
4 and increase the sample size of level 2 from 6 to 10. The result from the program showed that 
we now only need 2 schools instead of 3 schools. On the other hand, if we reduce the sample size 
of level two from 6 to 4, the program then indicated that we now will need 4 schools instead of 3 
schools. 
Now, fixing the total number of classrooms per school at 6, how many schools will we 
need if the class size is either larger or smaller? To answer this question, we go back to step 4 of 
the program and increase the sample size at level one (number of students per class) from 30 to 
40. The result suggests that we will need only 2 schools instead of 3 schools in this case. On the 
contrary, if we reduce the class size from 30 to 20, the result showed that we then need 4 schools 
instead of 3 schools in order to achieve the same power.  
Table 7.1 displays the results of a few different sample size combinations to achieve a 
power of 90% with 0.05   for the parameters given in the current study.  
 
Case 2: Randomize at Level Two with Interaction 
For further illustration, now let us assume that instead of randomizing at the student 
level, the researchers decide to randomly assign the classrooms in each school to the two study 
arms. In addition, we also assume that the treatment effect is not the same across schools. We 
now have a different study design where randomization takes place at the second level and an 
interaction effect between treatment and schools exists.  
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Table 7.1:  
Some Sample Size Combinations for the YouthMood Project Trial 
Randomizing at Level One without Interaction 
Class size Number of 
classrooms 
Number of Schools 
10 4 12 
 6 8 
 8 6 
 10 5 
20 4 6 
 6 4 
 8 3 
 10 3 
30 4 4 
 6 3 
 8 2 
 10 2 
40 4 3 
 6 2 
 8 2 
 10 2 
 
Assuming all other parameters remain the same, denote the variance of the interaction 
effect by 2ct . Suppose the magnitude of this new variance term is about 20% of the variance 
across schools, we obtain the following: 
2 20.20 0.216ct c     
2 2 2 2 2 36 1.08 1.72 0.216 33.98e T c p ct              
Again, assume for each school the researchers plan to select 6 classrooms each with a 
class size of 30. Given the algorithm in Figure 7.1, the steps in the program now can be modified 
as follows 
 Step 1: Continuous outcome 
 Step 2: Randomizing at level one with interaction between treatment and level three 
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 Step 3: Computing sample size at level three 
 Step 4: The parameters entered are 
o Proportion randomized to intervention arm 0.5  ,  
o Expected power  1 0.90   
o Significance level 0.05   
o Sample size of level two p=6 
o Sample size of level one n=30  
o Variance between schools 2 1.08c   
o Variance between classes 2 0.72p   
o Variance of the interaction between treatment and school  2 0.216ct 
o Residual variance  2 33.98e 
o The treatment difference needed to detect 1.8d   
Entering the above into the program, we obtain a total sample size of 8 schools in order 
to achieve a power of 90% with 0.05  . 
How would this sample size change if the number of classrooms per school changes? 
Going back to step 4 and increase the sample size of level two from 6 to 10, we see that only 7 
schools are needed instead of 8 schools. On the hand, if we reduce the sample size of level two 
from 6 to 4, the program then indicates that we need 10 schools instead of 8 schools as initially 
stated. 
To examine the effect of class size, we fix the total number of classrooms per school at 6 
and vary the number of students per classroom. Modifying step 4 of the program by increasing 
the sample size at level one (number of students per class) from 30 to 40. The result suggests that 
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we will only need 7 schools in this case. However, reducing the sample size at level one from 30 
to 20 indicates that we will need 9 schools instead of 6. Table 7.2 displays the results of a few 
sample size combinations to achieve a power of 90% with 0.05   for the parameters given in 
this hypothesized scenario. 
 
Table 7.2:  
Some Sample Size Combinations for the YouthMood Project Trial 
Randomizing at Level Two with Interaction 
Class size Number of classrooms Number of Schools 
10 4 17 
 6 13 
 8 11 
 10 9 
20 4 12 
 6 9 
 8 8 
 10 7 
30 4 10 
 6 8 
 8 7 
 10 7 
40 4 9 
 6 7 
 8 7 
 10 6 
 
 
7.3 Application Example for Binary Data 
Consider the Dutch Helping Hands Trial, where researchers studied methods to reduce 
hospital-acquired infections through a preventive measure –hand hygiene (Teerenstra et al., 
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2010). In this study, two methods to improve adherence to hand hygiene guidelines in hospitals 
were compared. Both methods targeted on changing the nurse behavior.  
The first method focused on the nurses (education, feedback) and the wards (facilities). 
The second method added other elements such as social influence in groups (norm and target 
setting within the nurse team). Random assignment took place at the ward level, i.e. each method 
is randomized to a subset of wards (level three), nurses (level two), and evaluations (level one). 
Evaluations were binary outcomes reflecting whether the guidelines are followed for each hand 
hygiene opportunity. 
In their power analysis, the researchers forecasted that the probabilities of adherence in 
the standard group and the group with extended strategy to be 0.60 and 0.70 respectively. It is 
assumed that the behavior of an individual nurse is fairly consistent and nurses within the same 
ward share some common working environment. Based on past studies, the intraclass correlation 
between the wards was set as 0.3   and the intraclass correlation between nurses (within the 
same ward) was set as . The suggested sample sizes were 3 evaluations on approximately 
15 nurses on each ward. Assuming the total variance was approximated at  based on the 
study report, and since the authors define 
0.6r 
2 0.1T 
2
2
c
T
   and 
2 2
2
c
T
r p
 

 , the variances of each level 
can be computed by: 
2 2 0.3 0.1 0.03c T        and   2 2 2 0.6 0.1 0.06c p Tr       
2 0.06 0.03 0.03p     
Using the parameters given above, we propose to compute the sample size under the 
context of three-level design using the formulas derived from our methods. The following steps 
in the program will be taken: 
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 Step 1: Binary outcome 
 Step 2: Randomizing at level three 
 Step 3: Computing sample size at level three 
 Step 4: The parameters entered are 
o Proportion randomized to intervention arm 0.5  ,  
o Expected power  1 0. 08   
o Significance level 0.05   
o Sample size of level two p=15 
o Sample size of level one n=3 
o Variance between wards 2  0.03c 
o Variance between nurses 2 0.03p   
o The probability of event in treatment group p-treat=0.7 
o The probability of event in control group p-control=0.6 
 
Inputting the above parameters into the sample size program, we arrive at a total sample 
size of 24 wards for a power of 80% and 0.05  . 
How would variation on the number of nurses per each ward affect this sample size 
results? Suppose the number of nurses (sample size at level 2) is increased from 15 to 20 nurses 
per each ward. Making this modification in the program shows that we now need only 20 wards. 
On the other hand, reducing the number of nurses per ward from 15 down to 10 brought the total 
wards required to achieve the same level of power up to 32 wards instead of 24. 
Suppose the number of nurses in each ward is fixed at 15. Adjusting sample size at the 
first level (number of evaluations) also affects the sample size results for level three.  Suppose 
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the number of evaluations is increased from 3 to 5 per nurse. This modification shows that we 
now need only 18 wards. On the other hand, reducing the number of evaluation per nurse from 3 
down to 2 brought the total wards required to achieve the same level of power up to 32 wards 
instead of 24 wards. Table 7.3 shows the sample size combinations for the given parameters 
described in step 4 above. 
 
Table 7.3:  
Some Sample Size Combinations for the Dutch Helping Hands Trial 
Randomization at Level Three 
Number of 
Evaluations  
Number of Nurses Number of Wards 
2 5 80 
 10 44 
 15 32 
 20 26 
4 5 44 
 10 26 
 15 20 
 20 18 
6 5 32 
 10 20 
 15 16 
 20 14 
8 5 26 
 10 18 
 15 14 
 20 12 
 
 
7.4 Comments on the Application Examples 
Above are a few examples to illustrate the use of the user-interface program and how our 
derived formulas can be applied to compute sample size in different study design settings. The 
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values chosen in Table 7.1, Table 7.2, and Table 7.3 were based on a range of typical sample 
sizes that were seen in similar studies. The program, however, was designed to be flexible and 
allow the users to specify any combination sets of parameters. For example, although only 
sample sizes at level one and level two were allowed to change, it should be noted that similar 
analyses can easily be done by looking at different sets of combinations of the desired power and 
different values of the intraclass correlation as well as varying the sample size at level three. 
The goal of the application examples was to demonstrate the use of our formulas and our 
program to provide the researchers with several trade-off options to achieve the appropriate 
sample sizes. A user manual is provided in Appendix A for more details on how to implement 
the SAS program. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 121
 
 
Chapter 8 
Discussion and Future Work 
 
This chapter presents the principal findings, discusses the results, and gives a list of 
future work that can build on the work presented here. We will start by providing a brief 
summary of the work that was detailed in previous chapters. We then will discuss the 
significance of this work by interpreting the results in light of our current knowledge about 
sample size and power in cluster randomized trials. Finally, we will suggest extensions for future 
work. 
 
8.1 Summary of Work 
Motivated by the need of a proper study design, this work provides sample size and 
power calculations for three-level cluster randomized trials. We considered a two-group 
comparison involving one treatment arm and one control arm. We assumed no covariates were 
included in the model. We proposed the relevant power functions in six important settings for 
two of the most popular outcomes: continuous and binary. The six scenarios depend on which 
level the allocation of treatment takes place and whether there is an interaction effect. They are: 
(1) Randomizing at level three 
(2) Randomizing at level two without interaction 
(3) Randomizing at level two with interaction between treatment and level three 
(4) Randomizing at level one without interaction 
(5) Randomizing at level one with interaction between level three and treatment 
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(6) Randomizing at level one with interaction between level two and treatment. 
We derived our power functions under the framework of generalized linear mixed model 
(GLMM) theory. For continuous outcomes, we used a robust variance estimator to derive the 
variance of the treatment effects. For binary outcomes, we applied the pseudo-likelihood 
approach to approximate the variance of the estimated treatment effects using a first-order Taylor 
series expansion. In the cases where the inverse of the correlation matrix could be written 
explicitly, we derived close forms for the design effects and for the power function respectively. 
For situations where a closed form solution does not exist, we proposed general formulas that 
yield satisfactory results for every setting. 
To assess the accuracy of our formulas, we conducted a simulation study in which we 
compared the empirical power and the estimated power. The simulation programs were written 
such that any set of parameters can be tested. We reported the simulation results for 27 
combinations of parameters per each design settings. We simulated 784 sets of data for each 
combination based on a margin of error of 0.035. Thus, altogether we had 21,168 sets of data for 
each of the six different scenarios per each type of outcome. The simulation results confirmed 
that our derived formulas for sample size and power are accurate under the conditions that we 
examined. 
Finally, we demonstrated the application of our power and sample size through the 
development of a user-interface SAS program. This program allows the researchers to calculate 
approximate sample sizes and power for a variety of design settings described above. To make 
the calculation, certain information is needed about the specific parameters. These parameters 
include the difference in the treatment effects, the variances of the random effects, the level of 
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significance alpha, and the proportion of the sample that is allocated into each treatment arm. We 
illustrated the use of the SAS program through some practical examples taken from past studies. 
8.2 Discussion 
In this work, we presented the relevant formulas to compute sample size and power for 
several important three-level study designs. Our formulas were derived based on the GLMM 
method, which has been proven to be a powerful technique to handle correlated outcomes. 
GLMM combines the properties of the two popular statistical frameworks, linear mixed models 
(which allows for random effects) and generalized linear models (which handle non-normal data 
via the use of the link functions and exponential family).  
As discussed in Chapter 2, statistical models that have been used for data with nested 
correlation structure are classified into two categories: the population-averaged (marginal) 
models or the cluster-specific (conditional) models. Each approach has its own advantages. Since 
GLMM is a subject-specific approach, our formulas estimated the parameters of the random 
effects for each subject, and estimated the fixed effect as a common factor. Thus, it makes 
specific use of the within-subject information as oppose to population-average approach. 
It should be noticed that our power functions were applicable only for two-arm trials. 
More specifically, we focused on the test for treatment contrast drawn from two treatment 
groups, not from multiple treatment effects. The reason behind this is that in most published 
literature, multilevel designs were chosen to achieve the power of a particular treatment contrast. 
Even when several treatments are being compared, typically there is always a contrast that plays 
the most important role to the researchers. Calculations for sample size and power would then be 
based on this main treatment contrast. 
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In some previous similar work, the sample size formulas were constructed from the Z-
test under asymptotic normal distribution (Campbell et al., 2004; Teerenstra et al., 2008; Dang et 
al., 2008). In multilevel design, however, power depends on the magnitude of the variance 
components that are usually unknown. Thus, a better choice of for the sampling distribution of 
the test statistic should be a t-distribution, which has a thicker tail than the normal distribution. 
To gain better accuracy for our results, we derived the power functions based on the CDF of a t- 
distribution, adjusting for appropriate degrees of freedom. This helped to avoid the 
overestimation of power from the same critical value based on the standard normal distribution. 
In this work we discussed different design situations where randomization can take place 
at any level. In the cases where an interation might occur, we considered only the two-way 
interaction effects. That is, we only looked at the interactions between treatment and level three 
or treatment and level two. While conceptionally a three-way interaction effect can happen, in 
reality this model is not practical. Firstly, from our observation the convergence rate of GLMM 
model with three-way interaction is very slow, especially for data with three-level structure. 
Secondly, in the design stage it is very difficult to pre-specify the variance of this three-way 
interaction term. Lastly, it is hard to avoid the confounding effect in models with three-way 
interaction. For example, a treatment effect that varies between physicians will also vary 
between practices, since physicians are nested within practices. 
Our power functions were derived from the unadjusted models where no covariate was 
included. However, sample sizes that include covariates other than treatment effect can be 
incorporated by following the same procedure. Our methods can be extended so that the 
correlation matrix will account for the presence of the covariates. Nevertheless, adding 
covariates into the models should not bring any significant changes in the magnitude of the 
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treatment effect, since in principle the covariates should not be related to the treatment. 
However, including covariates will affect the variance of each level and eventually will change 
the total variance. Generally, adding other covariates besides treatment will decrease the residual 
variance and increase the power. It will also reduce the degrees of freedom for the test statistics 
(Murray, 1998). Thus, the sample size formulas we presented here yield a more conservative 
result as oppose to methods where covariates are included. In addition, it is common for power 
and sample size software to account only for the treatment effect and not include the covariates. 
As always, one needs to specify the underlying correlation structure to compute power in 
a multilevel design study. In this work, we assumed the most convenient and the most common 
choice—the compound symmetry correlation structure. The nested exchangeable structure we 
used for the three-level design is a direct generalization of the exchangeable structure that is 
commonly used in two-level models. This structure is suitable when the units in level one are 
exchangeable within the level two units, and the level two units are exchangeable within the 
level three units. Although more complex correlation structures such as AR1 or Toeplitz can be 
applied, we argue that at the early design stage, it is doubtful that we know the true correlation 
structure unless some sensitivity analyses were conducted beforehand. In addition, a more 
complex correlation structure introduces theoretical difficulties that are not necessary at the 
design stage. 
Knowledge of plausible values of the variances or the two intraclass correlations is 
required for our computation. However, the ability to a priori postulate the intraclass correlation 
when designing a cluster randomized trial is limited. Such estimates are sparse in the literature, 
especially for three-level designs. To overcome this problem, a range of plausible values of the 
two intraclass correlations should be considered in order to assess the sensitivity of the results to 
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the misspecification of the parameters. Teerenstra et al. (2008) suggested that the researchers 
should examine the two-level intraclass correlations that are currently available in the literature 
and apply these values to the three-level models. Another way to facilitate the estimation of the 
intraclass correlation is to base on intermediate assessment of the within and between variances. 
Vierron and Giraudeau (2007) suggested that the recruitment can be flexible enough to be 
shortened or extended depending on the results of the internal pilot study. Thus, adjustment of 
the sample sizes to the intraclass correlation estimates can be done accordingly. 
Our methods made the assumption that all designs were balanced. Although in practice it 
is a natural consequence of recruitment process that the sample sizes can be unequal, it has been 
suggested that imbalance designs should be avoided as much as possible. The connection 
between imbalanced cluster sizes and power computation is intuitively obvious. Firstly, the 
estimates of small cluster sizes will be less accurate than those of larger cluster sizes in 
imbalanced designs. Secondly, the addition of more subjects into larger clusters does not 
compensate for the lost of precision in smaller clusters (Eldridge et al., 2006). Thus, our study 
was based on a balanced design, since imbalance might lead to biased estimates and decrease the 
reliability of the results. 
In this work we only examined power in the setting of a completely randomized design. 
Although other designs such as matched pairs and stratified randomized designs are also 
available, the completely randomized design is chosen for pragmatic reasons. First, it is the 
simplest and the most popular design in CRT. It allows for a wide number of statistical methods 
to be applied in the analysis steps and serves as a basis for deriving another sample size 
algorithm for more complex designs. Second, sensitivity analyses based on other designs can 
always be explored when needed. 
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In our simulation study, we examined a number of combinations defined by different 
values of the variances and sample sizes at each level. Although the number of parameters was 
limited, these parameters were selected from analysis of data of previous CRTs encountered in 
the literature. Therefore, the number of units on each level and the intraclass correlation were 
similar to those observed in this area of research. In addition, the simulation program was design 
in such a way that the same finding can be examined across a much larger number of scenarios. 
We speculate that similar conclusions would be obtained in these different settings. 
Most existing sample size calculators and software rely heavily on simulation algorithms. 
Such method is limited for the GLMM approach, since the convergence rate is very low for data 
with small or medium sample sizes. Besides, software based on simulations usually requires the 
users to specify the variance-covariance structures, which sometimes can be confusing and 
complicated. Our sample size program focuses on the user-friendly aspect. It computes sample 
sizes and power directly from SAS IML and provided the results much faster than does 
simulation. 
In most studies with a two-level design, either the clusters or the subjects within clusters 
can be randomized into different treatment conditions, suggesting that random assignment can be 
done at any level. The same logic holds for three-level designs, except that the nested structure is 
more complicated. While most previous work in power and sample size for three-level studies 
focused mainly on designs where random assignment takes place at the highest level, our study 
considered other situations that might be encountered in practice. Although the formulas we 
provided were model-specific, we present the results for a wide variety of different models 
corresponding to different designs. We allowed for the fact that randomization can occur at any 
level. We also considered the cases when interaction effects occurred, including the interaction 
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between treatment with each of the higher levels, level three and level two. By addressing the 
vast different designs, we provide a versatile tool to aid researchers in making their sample size 
decisions. 
 
8.3 Future work 
Taken as a whole, our study provided the general statistical formulas to compute power 
and sample size in three-level cluster randomized data under GLMM approach. It should be 
pointed out that the work presented here is just an initial step with many further steps to follow. 
Additional methodological and computational work is necessary and important in this research 
area. 
First, our methods only focused on continuous and binary data, whereas other types of 
data can be encountered in practice. By following the same path, we believe that relevant 
formulas for different types of data can be derived using the similar methods. For example, under 
the framework of GLMM different link functions can be selected and different variance 
structures can be constructed. Thus, future work on this topic can include extending the same set 
of formulas to ordinal, nominal, or count data.   
The extensions of this work to longitudinal correlated data at level 1 would be useful in 
practice. Although in our earlier discussion, we advocated for the use of compound symmetry 
variance-covariance structure in the design stage, there are certainly situations when other 
structures are more appropriate. For example, another area that we should investigate in our 
future work is to apply similar findings to repeated measures or longitudinal studies. Following 
the same procedure we can develop formulas that yield sample sizes requirement under other 
variance-covariance structures such as first-order autoregressive, toeplitz, or other more complex 
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structures with different variances at different time points. One of the advantages of our finding 
is the fact that as long as the variance structure is correctly specified, proper modifications can be 
implemented under GLMM models to address the sample size problem. Hence, future work for 
repeated measures and longitudinal studies is feasible. 
Our formulas were based on the assumption that all levels were treated as random. This 
assumption implies that the sample sizes of each level are selected randomly from a larger 
population. In practice, this does not always happen. In designing CRT, it is often the case that 
available number of clusters is somewhat limited. For example, consider a three-level CRT of 
center—physician—patient, where only three centers are available in the community. In this 
situation, if all three centers are selected in the study then it is more appropriate to treat center as 
a fixed effect rather than a random effect. Thus, another extension of our work is to examine 
situations where any level(s) can be treated as a fixed effect when the corresponding units of that 
level are not randomly selected. 
Even though our work provided methods for computing sample sizes, it did not account 
for the cost involved in the design stage. In any nested study, the units at each level have a cost 
associate with them and the researchers need to decide on a sample size which will minimize 
cost or be within a certain budget. Obviously, increasing sample sizes of any level can be a trade-
off between the gain in statistical power and the recruitment costs. Optimizing the choice of 
number of units per each level under certain budget constraints is another practical issue that we 
should examine. A cost function can be derived and used when costs for sampling an additional 
unit of any level can be quantified. In addition, minimum budget required for a given power or 
precision should also be examined separately for each design. 
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Although our user-interface program is a versatile tool for computing sample size and 
power for the designs under examination, it is by no means a final product. Several features can 
be added to the program, for example, the addition of a help menu, a printout option for final 
report, and more graphical descriptions of the power functions. The program can also serve as a 
foundation for the development of independent software – not necessarily on the SAS platform –  
to compute power and sample size for CRT. 
Finally, a number of complications in computing sample size and power in individual 
randomized studies can equally be seen in CRT. To name a few, these issues include: designs 
with more than one treatment group, designs with unequal sample sizes between treatment 
groups, matched-pair designs and stratified designs, trials with losses to follow-up and missing 
data, longitudinal designs with different attrition rates. These issues can be topics for future 
research. 
8.4 Concluding Remarks 
In the early stage of planning any clinical trial or experiment, it has been widely accepted 
that the evaluation of sample size is crucial. Sample size determination is an important task, as 
insufficient sample size can lead to inadequate power and inaccurate findings, whereas excessive 
sample size is a waste of resources.  
We contend that this work serves as a useful and practical application for sample size and 
power planning in three-level study designs. Our formulas and our user interface SAS program 
provides users with a quick tool to estimate sample size and power in a variety of different 
design settings.  
Finally, calculation of power and sample size involves more than simply making the best 
guesses about the parameters of a proposed analysis. It requires assumptions that typically cannot 
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be tested until the actual data have been collected. To obtain accurate results from our methods, 
researchers should be able to make reasonable estimates and assumptions on preliminary 
information that are available. If the inputs are inappropriate for the model under examination or 
if the wrong method is used, the wrong answer will emerge and the sample size results will no 
longer be appropriate for the study of interest. 
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Appendix A 
User’s Guide for the SAS Program 
 
 
This manual provides the researchers with a guide to effectively use the interface SAS 
program that was written to demonstrate the application of our work. The program was 
developed to address sample size and power questions for three-level study designs with 
continuous and binary outcomes. The formulas adopted in this program were derived in Chapter 
4 and Chapter 5. Application examples were presented in Chapter 7. 
When the users first run the program, a brief description will be shown on the screen to 
give basic instructions as to how to choose the options and how to move around in the program. 
The program consists of four steps. The users will: 
 Choose an option by typing x into the blank 
 Use TAB key to move from one field to another field 
 Press ENTER to move to the next step 
A.1 First step 
In the first step, the users will be asked to choose the type of outcomes for their 
experiment. The choices are either continuous or binary: 
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The selection is done by typing an x into the blank provided in front of the options. Here 
the users are required to select only one of the two options. If neither of the options were selected 
or both options were selected, an error message will appear to ask the users to re-enter their 
input. If the selection is done correctly, the program will move to the next step after the users hit 
ENTER.  The above screen shows an example when continuous outcome was chosen. 
A.2 Second step 
In the second step the users will be asked to choose the study design. There are six study 
designs available. The following screen will appear: 
 
Again, the users are required to select one of the six options by typing an x in the blanks. 
An error message will appear if none of the options was selected or more than one were selected. 
The above screen shows an example when randomization at level three was chosen. The users 
will hit ENTER to move to the next step. 
A.3 Third step 
 In the third step, the users will be asked to select what they desire to compute. The 
choices include sample sizes for the three levels or power. Again, one and only one option must 
be selected in order to move to the next step. An error message will appear if the instructions 
were not followed properly. 
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For demonstration, the following screen will appear if the users decide to compute level 
three sample size. 
 
A.4 Fourth step 
Hitting ENTER after the third step, the users will then be asked to enter certain 
parameters. The number of parameters depends on the options chosen in previous steps. The 
following lists all possible parameters and instruction on how to input them: 
Proportion of sample size allocated to treatment: 
By default, this proportion is set at 0.5 (equal allocation). However, any proportion can 
be chosen as long as the product of the chosen sample size at the corresponding level and this 
proportion is an integer. For example, suppose randomization takes place at level three and the 
researchers decide on a proportion of 0.6 for treatment arm. A sample size of 8 for level three 
will be an illegal input in this case since 0.6 × 8 = 4.8 is not an integer. However, a sample size 
of 10 for level three will be a valid input since 0.6 × 10 = 6 is an integer. 
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The power expected to achieve 
 Here the users are required to type in the value for the power expected to achieve in their 
study. These values typically range from 0.75 to 0.90. The input is required to be in decimal 
format. 
Level one (two, three) sample size 
For these parameters, the users are expected to type in their anticipated sample sizes for 
the corresponding levels. The numbers are supposed to be integers. 
Variance between level one (two, three) 
 These variances are usually computed from a pilot study or selected from previous 
studies. The variances are expected to be in integer or decimal formats. 
Variance of the interaction 
 If a design with interaction effect was selected in previous steps, the program will be 
prompted to ask for the variance of the interaction effects. Again, these variances are usually 
computed from a pilot study or selected from previous studies. They are expected to be in integer 
or decimal formats. 
Treatment difference 
 If the task is to calculate sample size or power for continuous outcome, users will be 
asked to input the difference of the two treatment means to be detected. Values of treatment 
difference are expected to be in integer or decimal formats. 
The probabilities of event in treatment group and control group 
If the task is to calculate sample size or power for binary outcome, users will be asked to 
input the expected control group proportion and the expected proportion in the intervention 
group. These proportions should be entered in decimal format. 
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Alpha 
 The level of significance alpha is set at a default value of 0.05. However, the default can 
be changed if the users wish to do so.  
 The following screen shows an example of the parameters input for step 4 when the 
requirement was to compute sample size at level three for continuous outcome where 
randomization takes place at level three. The sample size result is 8, after hitting ENTER after all 
parameters were provided. 
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After completing step 4, the users will be prompted to three options as follows 
 
To start a new calculation 
In choosing this option, the users will be brought to step one of a new calculation. All displays of 
the old screen will disappear. 
Modify previous calculation 
In choosing this option, the users will be brought back to the beginning of step 4 of the same 
calculation. All displays from the old screen will remain the same. The users are allowed to 
modify the parameters in step 4 and obtain the new result. 
End the program 
When this option is selected, the SAS program will stop running and the interface screen will be 
closed. 
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Appendix B 
Simulation Results 
 
 
 
The following tables in Appendix B showed results of the simulation study for different 
randomization schemes. For all tables, the notations are defined as follows: 
c: Sample size of level three 
p: Sample size of level two 
n: Sample size of level oneT  
d: The difference in treatment effect 
 : Estimated power based on simulation 
  : Theoretical power based on the derived formulas 
 : Proportion of sample size allocated to the treatment group 
c : Probability of the event of interest in control group (for binary cases) 
2
c : Variance between level three 
2
p : Variance between level two 
2
e : Variance between level one 
2
ct : Variance of the interaction between level three and treatment 
2
pt : Variance of the interaction between level three and treatment 
 
 
 
 145
 
Table B.1: Simulation Results for Case 1 
Randomize at Level Three—Continuous Outcome 
c p n d  95% CI of  
10 4 10 0.67 0.74 (0.65, 0.75) 
 20 0.64 0.71 (0.61, 0.79) 
 30 0.64 0.76 (0.67, 0.85) 
 8 10 0.49 0.74 (0.65, 0.83) 
 20 0.48 0.77 (0.69, 0.85) 
 30 0.47 0.67 (0.58, 0.76) 
 12 10 0.41 0.74 (0.65, 0.83) 
 20 0.40 0.75 (0.69, 0.77) 
 30 0.40 0.76 (0.54, 0.79) 
20 4 10 0.44 0.72 (0.63, 0.81) 
 20 0.42 0.73 (0.64, 0.82) 
 30 0.42 0.72 (0.63, 0.81) 
 8 10 0.32 0.79 (0.72, 0.88) 
 20 0.31 0.71 (0.62, 0.80) 
 30 0.31 0.76 (0.74, 0.76) 
 12 10 0.27 0.71 (0.62, 0.80) 
 20 0.26 0.85 (0.78, 0.92) 
 30 0.26 0.73 (0.64, 0.82) 
30 4 10 0.35 0.76 (0.63, 0.81) 
 20 0.34 0.76 (0.75, 0.78) 
 30 0.33 0.72 (0.63, 0.81) 
 8 10 0.26 0.73 (0.64, 0.82) 
 20 0.25 0.77 (0.61, 0.79) 
 30 0.25 0.73 (0.64, 0.82) 
 12 10 0.22 0.79 (0.71, 0.87) 
 20 0.21 0.72 (0.63, 0.81) 
 30 0.21 0.77 (0.74, 0.90) 
2
c =0.39, 
2
e=0.01, 
2
p =0.60, =0.75,      =0.5 
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Ta : S tio
on—Continuous Outcome 
ble B.2 imula n Results for Case 2 
Randomize at Level Two without Interacti
c p n d  95% CI of   
10 4 10 0.58 0.72 (0.68, 0.76) 
 20 0.56 0.70 (0.66, 0.77) 
 30 0.55 0.71 (0.67, 0.75) 
 8 10 0.40 0.75 (0.71, 0.78) 
 20 0.39 0.73 (0.72, 0.79) 
 30 0.38 0.73 (0.69, 0.76) 
 12 10 0.33 0.74 (0.71, 0.81) 
 20 0.31 0.78 (0.75, 0.80) 
 30 0.31 0.70 (0.65, 0.75) 
20 4 10 0.40 0.79 (0.76, 0.81) 
 20 0.39 0.78 (0.75, 0.80) 
 30 0.38 0.74 (0.70, 0.77) 
 8 10 0.28 0.77 (0.74, 0.79) 
 20 0.27 0.76 (0.72, 0.79) 
 30 0.27 0.76 (0.72, 0.79) 
 12 10 0.23 0.76 (0.72, 0.79) 
 20 0.22 0.75 (0.67, 0.82) 
 30 0.22 0.74 (0.69, 0.82) 
30 4 10 0.33 0.73 (0.69, 0.76) 
 20 0.32 0.76 (0.72, 0.79) 
 30 0.31 0.78 (0.75, 0.80) 
 8 10 0.23 0.78 (0.75, 0.80) 
 20 0.22 0.73 (0.69, 0.76) 
 30 0.22 0.75 (0.72, 0.82) 
 12 10 0.19 0.70 (0.65, 0.72) 
 20 0.18 0.73 (0.69, 0.76) 
 30 0.18 0.73 (0.69, 0.76) 
2
c =0.39, 
2
e=0.01, 
2
p =0.60, =0.75,      =0.5 
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Table B.3: Simulation Resu or Cas
Randomize at Level Tw ith In  
lts f e 3 
o w teraction—Continuous Outcome
c p n d  95% CI of   
10 4 10 0.69 0.70 (0.65, 0.77) 
 20 0.67 0.74 (0.74, 0.79) 
 30 0.67 0.75 (0.71, 0.76) 
 8 10 0.53 0.66 (0.61, 0.78) 
 20 0.52 0.71 (0.66, 0.76) 
 30 0.52 0.76 (0.71, 0.76) 
 12 10 0.47 0.76 (0.71, 0.76) 
 20 0.46 0.69 (0.64, 0.76) 
 30 0.45 0.68 (0.63, 0.80) 
20 4 10 0.46 0.70 (0.65, 0.77) 
 20 0.45 0.70 (0.65, 0.77) 
 30 0.44 0.72 (0.67, 0.75) 
 8 10 0.35 0.75 (0.70, 0.75) 
 20 0.35 0.74 (0.69, 0.76) 
 30 0.34 0.65 (0.60, 0.77) 
 12 10 0.31 0.71 (0.66, 0.76) 
 20 0.30 0.74 (0.69, 0.75) 
 30 0.30 0.77 (0.72, 0.79) 
30 4 10 0.37 0.74 (0.69, 0.74) 
 20 0.36 0.73 (0.71, 0.76) 
 30 0.35 0.74 (0.71, 0.76) 
 8 10 0.28 0.73 (0.72, 0.78) 
 20 0.28 0.74 (0.69, 0.75) 
 30 0.27 0.68 (0.63, 0.77) 
 12 10 0.25 0.73 (0.72, 0.79) 
 20 0.24 0.74 (0.73, 0.78) 
 30 0.24 0.77 (0.74, 0.79) 
2
c =0.39, 
2
e =0.55, 
2
ct=0.01, 
2
p =0.05, =0.75,       =0.5 
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Table B.4: Simulation Resu or Cas
Randomize at Level One wi ut Inte n—Con us Out
lts f e 4 
tho ractio tinuo come 
c p n d  95% CI of   
10 4 10 0.20 0.77 (0.76, 0.78) 
 20 0.14 0.82 (0.7, 0.82) 
 30 0.12 0.71 (0.69, 0.75) 
 8 10 0.14 0.76 (0.74, 0.78) 
 20 0.10 0.78 (0.74, 0.78) 
 30 0.08 0.67 (0.64, 0.84) 
 12 10 0.12 0.77 (0.75, 0.78) 
 20 0.08 0.74 (0.72, 0.76) 
 30 0.07 0.78 (0.75, 0.79) 
20 4 10 0.14 0.76 (0.74, 0.78) 
 20 0.10 0.76 (0.74, 0.78) 
 30 0.08 0.74 (0.72, 0.76) 
 8 10 0.10 0.74 (0.72, 0.76) 
 20 0.07 0.73 (0.71, 0.76) 
 30 0.06 0.73 (0.71, 0.76) 
 12 10 0.08 0.72 (0.68, 0.75) 
 20 0.06 0.74 (0.72, 0.76) 
 30 0.05 0.77 (0.75, 0.78) 
30 4 10 0.12 0.76 (0.73, 0.77) 
 20 0.08 0.77 (0.76, 0.78) 
 30 0.07 0.73 (0.71, 0.76) 
 8 10 0.08 0.75 (0.72, 0.77) 
 20 0.06 0.76 (0.74, 0.78) 
 30 0.05 0.73 (0.70, 0.76) 
 12 10 0.07 0.78 (0.75, 0.79) 
 20 0.05 0.76 (0.72, 0.81) 
 30 0.04 0.74 (0.72, 0.81) 
2
c =0.39, 
2
e=0.01, 
2
p =0.60, =0.75,      =0.5 
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Table B.5: Simulation Resu or Cas
Randomize at Level One wi reatm  Level Th Contin ome 
lts f e 5 
th T ent × ree— uous Outc
c p n d  95% CI of 
10 4 10 0.37 0.75 (0.73, 0.77)
 20 0.34 0.69 (0.67, 0.79)
 30 0.32 0.73 (0.72, 0.78)
 8 10 0.34 0.72 (0.70, 0.74)
 20 0.32 0.71 (0.70, 0.78)
 30 0.31 0.75 (0.73, 0.77)
 12 10 0.32 0.70 (0.69, 0.76)
 20 0.31 0.76 (0.71, 0.86)
 30 0.31 0.74 (0.72, 0.79)
20 4 10 0.25 0.72 (0.71, 0.79)
 20 0.22 0.71 (0.71, 0.8)
 30 0.22 0.70 (0.64, 0.78)
 8 10 0.22 0.74 (0.74, 0.78)
 20 0.21 0.75 (0.73, 0.77)
 30 0.21 0.74 (0.72, 0.76)
 12 10 0.22 0.75 (0.73, 0.81)
 20 0.21 0.71 (0.70, 0.78)
 30 0.20 0.73 (0.71, 0.76)
30 4 10 0.20 0.72 (0.68, 0.75)
 20 0.18 0.75 (0.74, 0.78)
 30 0.17 0.71 (0.69, 0.82)
 8 10 0.18 0.68 (0.66, 0.75)
 20 0.17 0.72 (0.68, 0.75)
 30 0.17 0.73 (0.71, 0.77)
 12 10 0.17 0.71 (0.70, 0.80)
 20 0.17 0.70 (0.70, 0.79)
 30 0.16 0.74 (0.72, 0.76)
2
c =0.39, 
2
e
2
ct=0.01, 2p =0.55, =0.05, =0.75,   =0.5  
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Table B.6: Simulation Results for Case 6 
Randomize at Level One with Treatment × Level Two—Con ous Outtinu come 
c p n d  95% CI of 
10 4 10 0.23 0.75 (0.61, 0.77)
 20 0.17 0.69 (0.65, 0.79)
 30 0 15. 0.73 (0.69, 0.77)
 8 10 0.16 0.74 (0.71, 0.76)
 20 0.12 0.74 (0.71, 0.77)
 30 0.10 0.72 (0.67, 0.75)
 12 10 0.13 0.70 (0.69, 0.77)
 20 0.10 0.74 (0.72, 0.76)
 30 0.08 0.72 (0.71, 0.78)
20 4 10 0.16 0.77 (0.75, 0.77)
 20 0.12 0.70 (0.64, 0.79)
 30 0.10 0.74 (0.73, 0.83)
 8 10 0.11 0.71 (0.68, 0.75)
 20 0.08 0.74 (0.71, 0.76)
 30 0.07 0.73 (0.72, 0.77)
 12 10 0.09 0.74 (0.71, 0.75)
 20 0.07 0.69 (0.68, 0.77)
 30 0.06 0.74 (0.71, 0.80)
30 4 10 0.13 0.71 (0.70, 0.76)
 20 0.10 0.72 (0.71, 0.77)
 30 0.08 0.73 (0.73, 0.79)
 8 10 0.09 0.75 (0.71, 0.77)
 20 0.07 0.72 (0.72, 0.77)
 30 0.06 0.71 (0.71, 0.78)
 12 10 0.07 0.74 (0.71, 0.77)
 20 0.06 0.70 (0.70, 0.77)
 30 0.05 0.75 (0.75, 0.79)
2
c =0.39, 
2
e=0.01, 
2
p
2
pt=0.55, =0.02, =0.75,   =0.5  
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Table B.7: Simulation Results for Case 7 
Randomize at Level Three—Bina  Outcomry e 
c p n d  95% CI of   
10 4 10 0.16 0.74 (0.73, 0.76) 
 20 0.14 0.77 (0.76, 0.86) 
 30 0.13 0.72 (0.71, 0.74) 
 8 10 0.12 0.72 (0.70, 0.73) 
 20 0.11 0.71 (0.70, 0.80) 
 30 0.10 0.74 (0.73, 0.79) 
 12 10 0.10 0.75 (0.74, 0.76) 
 20 0.09 0.71 (0.70, 0.83) 
 30 0.09 0.75 (0.74, 0.97) 
20 4 10 0.11 0.74 (0.71, 0.77) 
 20 0.10 0.70 (0.69, 0.80) 
 30 0.09 0.78 (0.77, 0.85) 
 8 10 0.08 0.75 (0.71, 0.76) 
 20 0.07 0.80 (0.79, 0.91) 
 30 0.07 0.76 (0.75, 0.84) 
 12 10 0.07 0.74 (0.72, 0.92) 
 20 0.06 0.75 (0.73, 0.77) 
 30 0.06 0.84 (0.74, 0.93) 
30 4 10 0.09 0.75 (0.73, 0.82) 
 20 0.08 0.74 (0.71, 0.84) 
 30 0.07 0.76 (0.72, 0.80) 
 8 10 0.07 0.71 (0.68, 0.85) 
 20 0.06 0.73 (0.71, 0.75) 
 30 0.06 0.84 (0.74, 0.94) 
 12 10 0.06 0.77 (0.73, 0.81) 
 20 0.05 0.76 (0.75, 0.85) 
 30 0.05 0.79 (0.76, 0.81) 
2
c =0.01, 
2
p =0.39, c =0.70, =0.75,      =0.5 
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Table B.8: Simulation Resu or Cas
Randomize at Level Two w ut Inte on—Bina utcome
lts f e 8 
itho racti ry O  
c p n d  95% CI of   
10 4 10 0.14 0.74 (0.71, 0.76) 
 20 0.12 0.73 (0.7, 0.75) 
 30 0.12 0.73 (0.69, 0.75) 
 8 10 0.10 0.70 (0.66, 0.72) 
 20 0.09 0.76 (0.73, 0.79) 
 30 0.09 0.73 (0.67, 0.78) 
 12 10 0.09 0.76 (0.73, 0.78) 
 20 0.08 0.78 (0.74, 0.82) 
 30 0.07 0.75 (0.73, 0.87) 
20 4 10 0.11 0.74 (0.70, 0.83) 
 20 0.09 0.76 (0.70, 0.83) 
 30 0.09 0.69 (0.65, 0.72) 
 8 10 0.08 0.78 (0.75, 0.80) 
 20 0.07 0.66 (0.46, 0.68) 
 30 0.06 0.68 (0.66, 0.76) 
 12 10 0.06 0.72 (0.65, 0.79) 
 20 0.05 0.73 (0.67, 0.78) 
 30 0.05 0.79 (0.75, 0.82) 
30 4 10 0.09 0.73 (0.70, 0.75) 
 20 0.08 0.73 (0.68, 0.76) 
 30 0.07 0.75 (0.60, 0.77) 
 8 10 0.06 0.71 (0.55, 0.79) 
 20 0.05 0.73 (0.67, 0.77) 
 30 0.05 0.85 (0.81, 0.88) 
 12 10 0.05 0.67 (0.60, 0.73) 
 20 0.04 0.75 (0.70, 0.79) 
 30 0.04 0.74 (0.57, 0.76) 
2
c =0.01, 
2
p =0.39, c =0.70, =0.75,      =0.5 
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Table B.9: Simulation Resu or Cas
Randomize at Level Two w y Outcome 
lts f e 9 
ith Interaction—Binar
c p n d  95% CI of   
10 4 10 0.16 0.72 (0.71, 0.73) 
 20 0.14 0.69 (0.67, 0.70) 
 30 0.13 0.75 (0.74, 0.76) 
 8 10 0.12 0.74 (0.72, 0.76) 
 20 0.11 0.72 (0.70, 0.75) 
 30 0.11 0.76 (0.72, 0.78) 
 12 10 0.11 0.73 (0.72, 0.77) 
 20 0.10 0.74 (0.68, 0.78) 
 30 0.09 0.75 (0.66, 0.78) 
20 4 10 0.11 0.77 (0.74, 0.78) 
 20 0.10 0.76 (0.74, 0.78) 
 30 0.09 0.70 (0.70, 0.76) 
 8 10 0.09 0.73 (0.71, 0.82) 
 20 0.08 0.78 (0.72, 0.83) 
 30 0.07 0.75 (0.74, 0.84) 
 12 10 0.08 0.74 (0.68, 0.78) 
 20 0.07 0.74 (0.68, 0.79) 
 30 0.07 0.75 (0.65, 0.82) 
30 4 10 0.09 0.75 (0.69, 0.76) 
 20 0.08 0.70 (0.70, 0.80) 
 30 0.08 0.74 (0.71, 0.87) 
 8 10 0.07 0.73 (0.65, 0.75) 
 20 0.06 0.71 (0.75, 0.86) 
 30 0.06 0.73 (0.65, 0.81) 
 12 10 0.06 0.70 (0.61, 0.78) 
 20 0.06 0.65 (0.57, 0.73) 
 30 0.05 0.69 (0.51, 0.86) 
2
c =0.70, 
2
ct=0.01, 
2
p =0.39, c =0.05, =0.75,       =0.5 
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Table B.10: Simulation Results for Case 10 
Randomize at Level One wi ut Inte n—Bina utcometho ractio ry O  
c p n d  95% CI of   
10 4 10 0.11 0.76 (0.68, 0.77) 
 20 0.08 0.75 (0.72, 0.82) 
 30 0.07 0.77 (0.76, 0.92) 
 8 10 0.08 0.74 (0.73, 0.89) 
 20 0.06 0.74 (0.73, 0.90) 
 30 0.05 0.77 (0.75, 0.95) 
 12 10 0.07 0.73 (0.71, 0.73) 
 20 0.05 0.77 (0.61, 0.80) 
 30 0.04 0.72 (0.69, 0.75) 
20 4 10 0.08 0.79 (0.67, 0.86) 
 20 0.06 0.80 (0.74, 0.79) 
 30 0.05 0.73 (0.69, 0.82) 
 8 10 0.06 0.68 (0.63, 0.78) 
 20 0.04 0.74 (0.64, 0.88) 
 30 0.04 0.76 (0.71, 0.77) 
 12 10 0.05 0.76 (0.74, 0.77) 
 20 0.04 0.78 (0.74, 0.79) 
 30 0.03 0.73 (0.67, 0.84) 
30 4 10 0.07 0.78 (0.65, 0.81) 
 20 0.05 0.75 (0.73, 0.86) 
 30 0.04 0.79 (0.68, 0.85) 
 8 10 0.05 0.72 (0.67, 0.82) 
 20 0.04 0.75 (0.70, 0.83) 
 30 0.03 0.76 (0.72, 0.77) 
 12 10 0.04 0.79 (0.65, 0.89) 
 20 0.03 0.79 (0.65, 0.89) 
 30 0.02 0.74 (0.69, 0.84) 
2
c =0.01, 
2
p =0.39, c =0.70, =0.75,      =0.5 
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Table B.11: Simulation Results for Case 11 
Randomize at Level One wi reatm  Level Th Binaryth T ent × ree—  Outcome 
c p n d  95% CI of 
10 4 10 0.13 0.73 (0.72, 0.77)
 20 0.10 0.73 (0.73, 0.74)
 30 0.09 0.75 (0.75, 0.77)
 8 10 0.10 0.73 (0.73, 0.84)
 20 0.09 0.71 (0.70, 0.83)
 30 0.08 0.74 (0.71, 0.82)
 12 10 0.09 0.73 (0.71, 0.77)
 20 0.08 0.74 (0.73, 0.79)
 30 0.07 0.70 (0.69, 0.78)
20 4 10 0.09 0.72 (0.70, 0.87)
 20 0.07 0.71 (0.69, 0.75)
 30 0.06 0.68 (0.65, 0.77)
 8 10 0.07 0.77 (0.75, 0.80)
 20 0.06 0.77 (0.72, 0.87)
 30 0.05 0.76 (0.68, 0.85)
 12 10 0.06 0.70 (0.69, 0.76)
 20 0.05 0.76 (0.69, 0.83)
 30 0.05 0.73 (0.68, 0.87)
30 4 10 0.08 0.74 (0.73, 0.76)
 20 0.06 0.71 (0.69, 0.86)
 30 0.05 0.74 (0.74, 0.75)
 8 10 0.06 0.70 (0.65, 0.77)
 20 0.05 0.73 (0.71, 0.87)
 30 0.04 0.75 (0.72, 0.86)
 12 10 0.05 0.74 (0.70, 0.80)
 20 0.04 0.66 (0.61, 0.87)
 30 0.04 0.75 (0.74, 0.77)
2
c =0.39, 
2
ct=0.01, 
2
p =0.05, =0.70, =0.75,   =0.5   c
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Table B 2: Simulation Results r Case 
Randomize at Level One with Treatment × Level Two—Binary Outc
.1  fo 12 
ome 
c p n d  95% CI of 
10 4 10 0.12 0.76 (0.72, 0.76)
 20 0.09 0.73 (0.73, 0.76)
 30 0.08 0.75 (0.75, 0.77)
 8 10 0.09 0.74 (0.73, 0.77)
 20 0.07 0.71 (0.70, 0.73)
 30 0.06 0.76 (0.71, 0.79)
 12 10 0.08 0.74 (0.71, 0.77)
 20 0.06 0.75 (0.73, 0.79)
 30 0.05 0.70 (0.69, 0.78)
20 4 10 0.09 0.72 (0.70, 0.87)
 20 0.06 0.75 (0.69, 0.76)
 30 0.05 0.73 (0.71, 0.78)
 8 10 0.06 0.70 (0.70, 0.79)
 20 0.05 0.73 (0.71, 0.77)
 30 0.04 0.74 (0.71, 0.76)
 12 10 0.05 0.70 (0.69, 0.76)
 20 0.04 0.76 (0.72, 0.78)
 30 0.03 0.70 (0.69, 0.77)
30 4 10 0.07 0.77 (0.73, 0.78)
 20 0.05 0.72 (0.70, 0.81)
 30 0.04 0.74 (0.74, 0.75)
 8 10 0.05 0.76 (0.75, 0.77)
 20 0.04 0.73 (0.71, 0.77)
 30 0.03 0.75 (0.72, 0.76)
 12 10 0.04 0.74 (0.70, 0.80)
 20 0.03 0.70 (0.70, 0.78)
 30 0.03 0.74 (0.73, 0.77)
2
c =0.01, 
2
p =0.39, 
2
pt =0.02, =0.70, =0.75,   =0.5  c 
